Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
positive regulation of mitotic cell cycle phase transition (GO:1901992),5/58,4.878290880659612e-7,4.450576870749385e-4,0,0,38.29996149403158,556.6248580265398,RB1;ANXA1;CDK1;CDC25C;CDC25A
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),3/8,1.0319053346498552e-6,4.450576870749385e-4,0,0,234.6,3233.7507104491183,CHRM1;CHRM4;CHRM5
mitotic cell cycle phase transition (GO:0044772),7/209,1.4372153511569595e-6,4.450576870749385e-4,0,0,14.557404676637876,195.83789876865944,RB1;CDK7;CDK1;NEK2;CDC25C;EIF4E;CDC25A
protein phosphorylation (GO:0006468),9/496,6.508276899376678e-6,0.0014590853097967902,0,0,7.991375770020534,95.43649226275387,BCKDK;MAP2K1;CDK7;RPS6KA1;ERBB2;CDK1;NEK2;NEK3;MTOR
phosphorylation (GO:0016310),8/400,1.1109219340954624e-5,0.0014590853097967902,0,0,8.675244010647738,98.96488666944651,BCKDK;MAP2K1;CDK7;ERBB2;CDK1;NEK2;NEK3;MTOR
regulation of protein serine/threonine kinase activity (GO:0071900),5/111,1.2246053912163527e-5,0.0014590853097967902,0,0,19.09896033885252,216.01510104096707,RB1;MAP2K1;CDK7;CDC25C;CDC25A
"protein localization to chromosome, centromeric region (GO:0071459)",3/17,1.231674227547144e-5,0.0014590853097967902,0,0,83.74789915966386,946.7324022615152,RB1;CDK1;CENPA
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),3/18,1.4751882567420537e-5,0.0014590853097967902,0,0,78.16078431372549,869.4714956192169,MAP2K1;ESR1;TP53
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),3/18,1.4751882567420537e-5,0.0014590853097967902,0,0,78.16078431372549,869.4714956192169,CHRM1;CHRM4;CHRM5
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",4/56,1.570597750050366e-5,0.0014590853097967902,0,0,30.606153846153845,338.5490276575585,RBL2;CDK1;CDC25C;TP53
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/20,2.0530658518209544e-5,0.0015539314892310317,0,0,68.95847750865052,744.3096195574882,CDK1;CDC25C;CDC25A
acetylcholine receptor signaling pathway (GO:0095500),3/21,2.3906724495892608e-5,0.0015539314892310317,0,0,65.12418300653594,693.0092755644479,CHRM1;CHRM4;CHRM5
cell cycle G1/S phase transition (GO:0044843),4/63,2.5118116743702212e-5,0.0015539314892310317,0,0,26.96542372881356,285.6156429789194,RB1;CDK7;EIF4E;CDC25A
G2/M transition of mitotic cell cycle (GO:0000086),5/130,2.631072562340013e-5,0.0015539314892310317,0,0,16.180408163265305,170.6310425351509,CDK7;CDK1;NEK2;CDC25C;CDC25A
cell cycle G2/M phase transition (GO:0044839),5/131,2.729907243592699e-5,0.0015539314892310317,0,0,16.05118237771299,168.67638342337293,CDK7;CDK1;NEK2;CDC25C;CDC25A
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4/65,2.843577536805978e-5,0.0015539314892310317,0,0,26.078688524590163,272.98812590322626,CHRM1;ANXA1;CHRM4;CHRM5
mitotic G1 DNA damage checkpoint signaling (GO:0031571),4/65,2.843577536805978e-5,0.0015539314892310317,0,0,26.078688524590163,272.98812590322626,RBL2;CDK1;CDC25C;TP53
positive regulation of cell cycle G2/M phase transition (GO:1902751),3/23,3.1712312522348865e-5,0.0016367076851812276,0,0,58.60588235294118,607.0869390782797,CDK1;CDC25C;CDC25A
negative regulation of apoptotic process (GO:0043066),8/485,4.4096286414401405e-5,0.002156076319946258,0,0,7.0983501959711965,71.19031230285906,RB1;ANXA1;CFL1;RPS6KA1;CDK1;CD27;RAF1;TP53
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",4/74,4.746598570011164e-5,0.0021704402504871345,0,0,22.71542857142857,226.14338540252248,RBL2;CDK1;CDC25C;TP53
anterograde trans-synaptic signaling (GO:0098916),6/244,4.906269672791154e-5,0.0021704402504871345,0,0,10.350840336134452,102.70529773129788,CHRM1;CHRM4;PRKACG;CHRM5;RPS6KA1;MBP
negative regulation of programmed cell death (GO:0043069),7/381,7.059770301363148e-5,0.0029811484590756203,0,0,7.794060757765388,74.4996306800459,ANXA1;CFL1;RPS6KA1;CDK1;CD27;RAF1;TP53
cellular protein modification process (GO:0006464),11/1025,7.62942008132812e-5,0.0030816222850234016,0,0,4.776202926471263,45.28276741391147,BCKDK;FGA;PPP2CB;MAP2K1;CDK7;ANXA1;ERBB2;CDK1;NEK2;NEK3;MTOR
G1/S transition of mitotic cell cycle (GO:0000082),4/85,8.171369001418152e-5,0.0031630007509656096,0,0,19.619753086419752,184.66678626990836,RB1;CDK7;EIF4E;CDC25A
protein localization to chromosome (GO:0034502),3/34,1.0492510084808428e-4,0.003899016747514811,0,0,37.78937381404175,346.23621125249724,RB1;CENPA;ESR1
regulation of mitotic cell cycle (GO:0007346),5/178,1.1727752312709176e-4,0.004035215517965491,0,0,11.662734457945028,105.5590298327731,RB1;CDK1;NEK2;CDC25C;EIF4E
regulation of translation (GO:0006417),5/178,1.1727752312709176e-4,0.004035215517965491,0,0,11.662734457945028,105.5590298327731,RPS6KA1;ERBB2;FOXO3;EIF4E;MTOR
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/37,1.354635173682446e-4,0.00449448598696783,0,0,34.449826989619375,306.83800146502136,AR;H3C13;ESR1
regulation of cell cycle (GO:0051726),6/296,1.420470765844047e-4,0.004522394450955832,0,0,8.472413793103449,75.06009633746545,RB1;NR4A1;MAP2K1;CDK7;TP53;CDC25A
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),2/7,1.489595205901835e-4,0.004522394450955832,0,0,153.3923076923077,1351.6678533430645,ESR1;TP53
regulation of apoptotic process (GO:0042981),9/742,1.5090874917075432e-4,0.004522394450955832,0,0,5.242291950886767,46.12606301924693,ANXA1;BAD;CFL1;RPS6KA1;CDK1;CD27;RAF1;FOXO3;TP53
positive regulation of protein localization to membrane (GO:1905477),4/101,1.5959893846293825e-4,0.004633356682252176,0,0,16.370309278350515,143.12310157439435,BAD;KCNB1;ERBB2;TP53
chemical synaptic transmission (GO:0007268),6/306,1.7013772131478806e-4,0.004789634639437519,0,0,8.185833333333333,71.0440479365106,CHRM1;CHRM4;PRKACG;CHRM5;RPS6KA1;MBP
zymogen activation (GO:0031638),3/45,2.4364414080655457e-4,0.006467129085307501,0,0,27.876750700280112,231.9290416731333,FGA;C1R;BAD
cytokine-mediated signaling pathway (GO:0019221),8/621,2.436485661848897e-4,0.006467129085307501,0,0,5.484928009078658,45.6334144998426,RAP1B;ANXA1;H3C13;CFL1;CD27;FOXO3;TP53;CAMK2G
regulation of cell growth (GO:0001558),5/217,2.9469405792045616e-4,0.007564097439598323,0,0,9.498459761262996,77.21842041693708,RB1;RPS6KA1;ERBB2;TP53;MTOR
response to glucose (GO:0009749),3/49,3.139389889918914e-4,0.007564097439598323,0,0,25.44757033248082,205.26803923379185,GYS2;PFKL;KCNB1
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),2/10,3.175455329863666e-4,0.007564097439598323,0,0,95.85576923076924,772.1076136521657,ESR1;TP53
positive regulation of transcription by RNA polymerase III (GO:0045945),2/10,3.175455329863666e-4,0.007564097439598323,0,0,95.85576923076924,772.1076136521657,AR;MTOR
regulation of lipid kinase activity (GO:0043550),2/11,3.8743995530845664e-4,0.008778822401989177,0,0,85.2008547008547,669.3336268156615,RB1;RBL2
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),2/11,3.8743995530845664e-4,0.008778822401989177,0,0,85.2008547008547,669.3336268156615,MAP2K1;TP53
regulation of cyclin-dependent protein kinase activity (GO:1904029),3/54,4.186434747021948e-4,0.009259994952341406,0,0,22.946943483275664,178.49259097472682,CDK7;CDC25C;CDC25A
transcription initiation from RNA polymerase II promoter (GO:0006367),4/140,5.544403190921805e-4,0.011978489684572925,0,0,11.652941176470588,87.36852528141513,AR;NR4A1;CDK7;ESR1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),3/60,5.710031497039948e-4,0.012055952865341163,0,0,20.525283797729617,153.28519689031296,CHRM1;CHRM4;CHRM5
Ras protein signal transduction (GO:0007265),4/142,5.848362427644994e-4,0.012073619322849331,0,0,11.482898550724638,85.48074853936357,RB1;RAP1B;CFL1;TP53
positive regulation of intracellular protein transport (GO:0090316),4/148,6.831245726475648e-4,0.01351229068384126,0,0,11.001111111111111,80.18526527449423,BAD;KCNB1;ERBB2;TP53
cellular component assembly (GO:0022607),5/261,6.83614275716404e-4,0.01351229068384126,0,0,7.848373724489796,57.19986379607173,VASP;FGA;DCX;TP53;ADD2
regulation of G2/M transition of mitotic cell cycle (GO:0010389),4/149,7.005744961011068e-4,0.01355903555995684,0,0,10.924689655172411,79.35268339626775,CDK1;NEK2;CDC25C;CDC25A
steroid hormone mediated signaling pathway (GO:0043401),2/15,7.345555571872974e-4,0.013926573727081617,0,0,58.97337278106509,425.56630208545965,AR;ESR1
protein deubiquitination (GO:0016579),5/267,7.572587427027948e-4,0.014069867439417924,0,0,7.666303162486368,55.08856391103979,AR;CDK1;TP53;ESR1;CDC25A
cellular response to decreased oxygen levels (GO:0036294),3/69,8.59406908989732e-4,0.015654686636303157,0,0,17.718360071301248,125.07865310256418,BAD;TP53;MTOR
protein modification by small protein removal (GO:0070646),5/276,8.786642996076442e-4,0.015697675660298106,0,0,7.408313879057158,52.13310223439203,AR;CDK1;TP53;ESR1;CDC25A
regulation of G1/S transition of mitotic cell cycle (GO:2000045),3/71,9.339394663847564e-4,0.0163114887609124,0,0,17.195501730103807,119.95752127155308,RB1;RBL2;ANXA1
regulation of metal ion transport (GO:0010959),2/17,9.481382056935088e-4,0.0163114887609124,0,0,51.1051282051282,355.7433227832543,CACNA2D1;CAMK2G
chromatin assembly (GO:0031497),3/73,0.001012452058887815,0.01710123568557782,0,0,16.702521008403362,115.17023113736498,H3C13;H2BC3;TP53
intracellular estrogen receptor signaling pathway (GO:0030520),2/18,0.001064812220373368,0.017664474155836767,0,0,47.90865384615385,327.93266660649385,AR;ESR1
"DNA-templated transcription, initiation (GO:0006352)",4/168,0.00109533975496204,0.017827342135080096,0,0,9.649756097560976,65.77940250600767,AR;NR4A1;CDK7;ESR1
"positive regulation of transcription, DNA-templated (GO:0045893)",10/1183,0.001113009519735894,0.017827342135080096,0,0,3.637332403317058,24.736361566926465,AR;NR4A1;MAP2K1;CDK7;RPS6KA1;ERBB2;FOXO3;TP53;ESR1;MTOR
regulation of nuclear division (GO:0051783),2/20,0.0013177506939226456,0.02026581761303627,0,0,42.58119658119658,282.3912150075315,NEK2;CDC25C
insulin secretion (GO:0030073),2/20,0.0013177506939226456,0.02026581761303627,0,0,42.58119658119658,282.3912150075315,ANXA1;CAMK2G
MAPK cascade (GO:0000165),5/303,0.0013306941597365043,0.02026581761303627,0,0,6.727845500616354,44.55215989754786,MAP2K1;ERBB2;CDK1;MBP;RAF1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),3/82,0.0014171544131430182,0.02123445886790103,0,0,14.793000744601638,97.0288355680606,CDK7;CDC25C;CDC25A
regulation of transcription by RNA polymerase III (GO:0006359),2/21,0.0014539455822740843,0.02143992771321626,0,0,40.33805668016194,263.5476577125423,AR;MTOR
regulation of cell cycle G2/M phase transition (GO:1902749),3/85,0.0015715511019872403,0.022812046464783534,0,0,14.249641319942612,91.9912980980468,CDK1;NEK2;TP53
negative regulation of gene expression (GO:0010629),5/322,0.0017387604040824045,0.023502538613241024,0,0,6.318483229253847,40.15132504713532,RB1;RBL2;MAP2K1;H3C13;ESR1
ERK1 and ERK2 cascade (GO:0070371),2/23,0.001745613739842444,0.023502538613241024,0,0,36.49267399267399,231.752166218624,MAP2K1;CDK1
response to nutrient levels (GO:0031667),2/23,0.001745613739842444,0.023502538613241024,0,0,36.49267399267399,231.752166218624,KCNB1;MTOR
positive regulation of transcription by RNA polymerase I (GO:0045943),2/23,0.001745613739842444,0.023502538613241024,0,0,36.49267399267399,231.752166218624,ERBB2;MTOR
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),2/23,0.001745613739842444,0.023502538613241024,0,0,36.49267399267399,231.752166218624,ESR1;TP53
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/89,0.001793261921908923,0.023799147506477,0,0,13.584131326949384,85.9022295713123,BAD;RPS6KA1;RAF1
negative regulation of macromolecule metabolic process (GO:0010605),4/194,0.00185866457318325,0.024319709697003374,0,0,8.318315789473685,52.30471306844914,RB1;RBL2;MAP2K1;ESR1
positive regulation of protein targeting to membrane (GO:0090314),2/24,0.001901018240228249,0.02452841590516727,0,0,34.83216783216783,218.23626682147088,KCNB1;ERBB2
regulation of epithelial cell proliferation (GO:0050678),3/93,0.002033596518985928,0.02521449502205353,0,0,12.977777777777778,80.43560959243626,NR4A1;BAD;ERBB2
regulation of heterotypic cell-cell adhesion (GO:0034114),2/25,0.002062757396852603,0.02521449502205353,0,0,33.31605351170568,206.01686820131164,FGA;MBP
response to hexose (GO:0009746),2/25,0.002062757396852603,0.02521449502205353,0,0,33.31605351170568,206.01686820131164,GYS2;PFKL
positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/25,0.002062757396852603,0.02521449502205353,0,0,33.31605351170568,206.01686820131164,BAD;TP53
regulation of kinase activity (GO:0043549),3/94,0.0020966534414301767,0.02529598762452772,0,0,12.834518422753716,79.15577326267173,RB1;RBL2;ERBB2
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/26,0.0022307971565230693,0.02623304504316369,0,0,31.92628205128205,194.92260392854524,BAD;TP53
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/26,0.0022307971565230693,0.02623304504316369,0,0,31.92628205128205,194.92260392854524,BAD;TP53
peptide hormone secretion (GO:0030072),2/27,0.002405103597341798,0.02724806392598208,0,0,30.647692307692303,184.81055875222285,ANXA1;CAMK2G
positive regulation of gene silencing by miRNA (GO:2000637),2/27,0.002405103597341798,0.02724806392598208,0,0,30.647692307692303,184.81055875222285,MAP2K1;TP53
mitotic chromosome condensation (GO:0007076),2/27,0.002405103597341798,0.02724806392598208,0,0,30.647692307692303,184.81055875222285,RB1;CDK1
positive regulation of nucleic acid-templated transcription (GO:1903508),6/511,0.0024691748256965985,0.027636908591230604,0,0,4.812128712871287,28.89140129221963,AR;MAP2K1;RPS6KA1;FOXO3;TP53;ESR1
positive regulation of cellular protein metabolic process (GO:0032270),3/102,0.0026451820800154568,0.029254454194456665,0,0,11.79263220439691,69.9894534650505,BAD;ERBB2;MTOR
regulation of protein targeting to membrane (GO:0090313),2/29,0.002772381493139292,0.03030049890736944,0,0,28.37464387464388,167.0712816687644,KCNB1;ERBB2
regulation of catecholamine secretion (GO:0050433),2/30,0.0029652857587718945,0.03203198220812895,0,0,27.35989010989011,159.25595242218557,KCNB1;KCNA2
regulation of cellular amide metabolic process (GO:0034248),2/32,0.003369457930597071,0.035979613994536544,0,0,25.53333333333333,145.3613534547405,FOXO3;EIF4E
protein-containing complex subunit organization (GO:0043933),3/112,0.0034453415241381883,0.03637184404459519,0,0,10.70534268753373,60.70713195324601,FGA;TP53;ADD2
regulation of autophagy (GO:0010506),4/231,0.003489467886526796,0.03642377153464487,0,0,6.94942731277533,39.319901588164974,BAD;FOXO3;EIF4E;MTOR
response to lipid (GO:0033993),3/114,0.003621210497269949,0.03737893946626425,0,0,10.511393746687864,59.08398627938719,ANXA1;FOXO3;ESR1
cellular response to vascular endothelial growth factor stimulus (GO:0035924),2/34,0.003797893801950445,0.03757986135151411,0,0,23.935096153846157,133.3976779195181,NR4A1;ANXA1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),2/34,0.003797893801950445,0.03757986135151411,0,0,23.935096153846157,133.3976779195181,BAD;TP53
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),2/34,0.003797893801950445,0.03757986135151411,0,0,23.935096153846157,133.3976779195181,FOXO3;TP53
tumor necrosis factor-mediated signaling pathway (GO:0033209),3/116,0.0038024832799163897,0.03757986135151411,0,0,10.32431025507548,57.52809878392557,CD27;FOXO3;TP53
positive regulation of protein-containing complex assembly (GO:0031334),3/118,0.003989210814659552,0.0385116296434403,0,0,10.143734015345268,56.03562854988992,RAP1B;TP53;ESR1
negative regulation of cell cycle G1/S phase transition (GO:1902807),2/35,0.0040211281759028085,0.0385116296434403,0,0,23.208624708624708,128.02324793427923,RB1;RBL2
response to estrogen (GO:0043627),2/35,0.0040211281759028085,0.0385116296434403,0,0,23.208624708624708,128.02324793427923,AR;ESR1
negative regulation of cellular process (GO:0048523),6/566,0.004084382141622298,0.0387182756078277,0,0,4.327232142857143,23.80230740572671,RB1;AR;NR4A1;MAP2K1;RAF1;TP53
regulation of androgen receptor signaling pathway (GO:0060765),2/36,0.004250329791188123,0.039485563760137656,0,0,22.524886877828056,123.00297201006306,AR;H3C13
regulation of embryonic development (GO:0045995),2/36,0.004250329791188123,0.039485563760137656,0,0,22.524886877828056,123.00297201006306,CFL1;CDK1
potassium ion transport (GO:0006813),3/122,0.004379227716379815,0.040280223252642064,0,0,9.800790904597132,53.226947638137325,KCNB1;KCNA2;KCNA3
positive regulation of epithelial cell proliferation (GO:0050679),3/123,0.0044802173347095785,0.04045629060636929,0,0,9.718627450980392,52.55915091316412,NR4A1;BAD;ERBB2
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/37,0.004485466019866562,0.04045629060636929,0,0,21.88021978021978,118.30444220257536,RB1;RBL2
response to estradiol (GO:0032355),2/38,0.0047265043601269615,0.04222040913998026,0,0,21.271367521367523,113.8990133200568,ANXA1;ESR1
positive regulation of macromolecule biosynthetic process (GO:0010557),3/129,0.005115875703046242,0.045263319315523416,0,0,9.253034547152197,48.813520364788914,AR;ERBB2;MTOR
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.005226158001712535,0.04537477367842004,0,0,20.149797570850204,105.86862582436255,BAD;TP53
positive regulation of wound healing (GO:0090303),2/40,0.005226158001712535,0.04537477367842004,0,0,20.149797570850204,105.86862582436255,ANXA1;MTOR
cellular response to hypoxia (GO:0071456),3/131,0.005339216401671557,0.04592714849215626,0,0,9.107536764705882,47.6567924907854,BAD;TP53;MTOR
regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,0.005484708931963944,0.04674582199811472,0,0,19.63214990138067,102.20087423124885,BAD;TP53
protein-containing complex assembly (GO:0065003),4/267,0.005820438341299945,0.04862385207932288,0,0,5.987224334600761,30.81252979709028,FGA;BAD;TP53;ADD2
central nervous system development (GO:0007417),4/268,0.005896959028546826,0.04862385207932288,0,0,5.964242424242424,30.616355854578387,PPP1R17;MARCKS;DCX;MBP
cellular response to glucose starvation (GO:0042149),2/43,0.006019099019507137,0.04862385207932288,0,0,18.672607879924957,95.46963998767032,FOXO3;TP53
development of primary male sexual characteristics (GO:0046546),2/43,0.006019099019507137,0.04862385207932288,0,0,18.672607879924957,95.46963998767032,AR;PRKACG
positive regulation of peptide hormone secretion (GO:0090277),2/43,0.006019099019507137,0.04862385207932288,0,0,18.672607879924957,95.46963998767032,FGA;BAD
male gonad development (GO:0008584),2/43,0.006019099019507137,0.04862385207932288,0,0,18.672607879924957,95.46963998767032,AR;PRKACG
potassium ion transmembrane transport (GO:0071805),3/139,0.006290963753199756,0.049982380023640506,0,0,8.568339100346021,43.42983486679253,KCNB1;KCNA2;KCNA3
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/44,0.00629487455626043,0.049982380023640506,0,0,18.227106227106223,92.3753305021316,AR;ESR1
action potential (GO:0001508),2/45,0.006576328212641212,0.05049098272350154,0,0,17.802325581395348,89.44384543900023,KCNB1;KCNA2
chromosome condensation (GO:0030261),2/45,0.006576328212641212,0.05049098272350154,0,0,17.802325581395348,89.44384543900023,RB1;CDK1
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),2/45,0.006576328212641212,0.05049098272350154,0,0,17.802325581395348,89.44384543900023,FOXO3;TP53
positive regulation of RNA metabolic process (GO:0051254),2/45,0.006576328212641212,0.05049098272350154,0,0,17.802325581395348,89.44384543900023,MAP2K1;TP53
chromatin organization (GO:0006325),3/142,0.006672301288389439,0.0506041672013326,0,0,8.382141345746932,41.992771729958896,RB1;H3C13;ESR1
protein-DNA complex assembly (GO:0065004),3/143,0.006802412369738072,0.0506041672013326,0,0,8.321848739495799,41.53000279960744,CDK7;H3C13;H2BC3
regulation of telomerase activity (GO:0051972),2/46,0.006863428490169976,0.0506041672013326,0,0,17.396853146853147,86.66326216943813,NEK2;TP53
interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.006863428490169976,0.0506041672013326,0,0,17.396853146853147,86.66326216943813,RAP1B;CFL1
posttranscriptional regulation of gene expression (GO:0010608),2/46,0.006863428490169976,0.0506041672013326,0,0,17.396853146853147,86.66326216943813,FOXO3;EIF4E
nervous system development (GO:0007399),5/447,0.007018965609033817,0.05134345709285367,0,0,4.502724166589712,22.329636916162585,PPP1R17;MARCKS;CHRM1;DCX;MBP
cellular response to interleukin-12 (GO:0071349),2/48,0.007454443516934324,0.0541029533377499,0,0,16.638795986622075,81.51254605805195,RAP1B;CFL1
cellular response to organic cyclic compound (GO:0071407),3/150,0.007755613041421684,0.05544197593244456,0,0,7.922769107643057,38.499416431328434,RAP1B;AR;ESR1
regulation of cellular protein metabolic process (GO:0032268),2/49,0.00775829587859827,0.05544197593244456,0,0,16.28396072013093,79.12364418473429,FOXO3;EIF4E
regulation of cellular component movement (GO:0051270),2/50,0.008067670084263163,0.05721271380366777,0,0,15.943910256410255,76.8479024006269,ERBB2;RAF1
gonad development (GO:0008406),2/51,0.008382535244155703,0.05858664847803696,0,0,15.617739403453688,74.6778588702288,AR;PRKACG
regulation of cellular macromolecule biosynthetic process (GO:2000112),5/468,0.008471513062839319,0.05858664847803696,0,0,4.293868735399127,20.48624589172909,RB1;FOXO3;TP53;EIF4E;ESR1
regulation of cell differentiation (GO:0045595),3/156,0.008632466586165347,0.05858664847803696,0,0,7.609765474817378,36.16331772907102,AR;RPS6KA1;RAF1
peptidyl-serine phosphorylation (GO:0018105),3/156,0.008632466586165347,0.05858664847803696,0,0,7.609765474817378,36.16331772907102,RPS6KA1;CDK1;MTOR
regulation of signal transduction by p53 class mediator (GO:1901796),3/156,0.008632466586165347,0.05858664847803696,0,0,7.609765474817378,36.16331772907102,CDK1;TP53;MTOR
regulation of exocytosis (GO:0017157),2/52,0.008702860592001184,0.05858664847803696,0,0,15.304615384615383,72.6066794687417,FGA;ANXA1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.008702860592001184,0.05858664847803696,0,0,15.304615384615383,72.6066794687417,BAD;TP53
cellular response to growth factor stimulus (GO:0071363),3/158,0.008937174124899798,0.05930453401451366,0,0,7.510815939278937,35.43254332994102,NR4A1;ANXA1;ERBB2
cellular response to starvation (GO:0009267),3/158,0.008937174124899798,0.05930453401451366,0,0,7.510815939278937,35.43254332994102,FOXO3;TP53;MTOR
negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/53,0.009028615477782772,0.059481338901849125,0,0,15.003770739064857,70.62809393251956,RPS6KA1;RAF1
protein autophosphorylation (GO:0046777),3/159,0.009091873115244968,0.059481338901849125,0,0,7.462292609351433,35.075568614523775,ERBB2;NEK2;MTOR
positive regulation of gene expression (GO:0010628),5/482,0.009548832559180494,0.06203402410824251,0,0,4.164848329268814,19.37211053892404,AR;MAP2K1;ERBB2;TP53;MTOR
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.009696291882368669,0.06255454971333675,0,0,14.436139332365748,66.92611152225938,RPS6KA1;RAF1
negative regulation of transcription by RNA polymerase II (GO:0000122),6/684,0.010033955928513584,0.06387290316865589,0,0,3.5523598820059,16.347179883895762,RB1;AR;ERF;FOXO3;TP53;ESR1
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),2/56,0.010038152704654208,0.06387290316865589,0,0,14.168091168091168,65.19251879575016,BAD;TP53
cellular response to peptide (GO:1901653),2/57,0.010385321677248704,0.06477524135362267,0,0,13.90979020979021,63.53104510332115,CACNA2D1;TP53
regulation of mitotic nuclear division (GO:0007088),2/57,0.010385321677248704,0.06477524135362267,0,0,13.90979020979021,63.53104510332115,NEK2;CDC25C
positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.010714687661455167,0.06477524135362267,0,0,3.148156894230996,14.2804797849927,AR;NR4A1;CDK7;RPS6KA1;FOXO3;TP53;ESR1
peptidyl-serine modification (GO:0018209),3/169,0.010725628089219992,0.06477524135362267,0,0,7.00921332388377,31.78761829202504,RPS6KA1;CDK1;MTOR
regulation of calcium ion transport (GO:0051924),2/58,0.010737768749685564,0.06477524135362267,0,0,13.660714285714286,61.93751413619027,CACNA2D1;CAMK2G
nucleosome assembly (GO:0006334),2/58,0.010737768749685564,0.06477524135362267,0,0,13.660714285714286,61.93751413619027,H3C13;H2BC3
positive regulation of mitochondrion organization (GO:0010822),2/58,0.010737768749685564,0.06477524135362267,0,0,13.660714285714286,61.93751413619027,BAD;TP53
positive regulation of protein binding (GO:0032092),2/58,0.010737768749685564,0.06477524135362267,0,0,13.660714285714286,61.93751413619027,PPP2CB;ADD2
transcription by RNA polymerase II (GO:0006366),4/320,0.010857010376765952,0.06507201703235851,0,0,4.969620253164557,22.477315547347757,AR;NR4A1;CDK7;ESR1
negative regulation of autophagy (GO:0010507),2/59,0.011095463990631825,0.06523851928668964,0,0,13.42037786774629,60.40805855278045,EIF4E;MTOR
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.011095463990631825,0.06523851928668964,0,0,13.42037786774629,60.40805855278045,BAD;TP53
mitotic DNA damage checkpoint signaling (GO:0044773),2/59,0.011095463990631825,0.06523851928668964,0,0,13.42037786774629,60.40805855278045,CDK1;TP53
peptidyl-threonine phosphorylation (GO:0018107),2/60,0.011458377583512931,0.06653020484427197,0,0,13.188328912466844,58.93909228909847,MAP2K1;CDK1
response to organic cyclic compound (GO:0014070),2/60,0.011458377583512931,0.06653020484427197,0,0,13.188328912466844,58.93909228909847,ANXA1;ESR1
"regulation of DNA-templated transcription, initiation (GO:2000142)",2/61,0.011826479837562529,0.06824099235463098,0,0,12.964146023468055,57.52728575404862,CDK1;TP53
positive regulation of developmental process (GO:0051094),3/177,0.0121475554277405,0.06966098143438842,0,0,6.684246112237998,29.48171857507416,AR;CFL1;RPS6KA1
amyloid fibril formation (GO:1990000),2/63,0.012578132119592555,0.07048071332170557,0,0,12.53783102143758,54.862984800252825,FGA;H3C13
organonitrogen compound catabolic process (GO:1901565),2/63,0.012578132119592555,0.07048071332170557,0,0,12.53783102143758,54.862984800252825,BCKDK;MTOR
protein secretion (GO:0009306),2/64,0.012961623339762796,0.07048071332170557,0,0,12.334987593052109,53.60492452410381,ANXA1;CAMK2G
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/64,0.012961623339762796,0.07048071332170557,0,0,12.334987593052109,53.60492452410381,CDK1;TP53
alpha-beta T cell differentiation (GO:0046632),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,ANXA1
bone marrow development (GO:0048539),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,TP53
bundle of His cell action potential (GO:0086043),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,CACNA2D1
cellular response to antibiotic (GO:0071236),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,TP53
cellular response to nicotine (GO:0071316),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,BAD
cellular response to testosterone stimulus (GO:0071394),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,AR
regulation of integrin biosynthetic process (GO:0045113),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,AR
positive regulation of amine transport (GO:0051954),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,KCNB1
positive regulation of long-term synaptic depression (GO:1900454),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,KCNB1
positive regulation of metallopeptidase activity (GO:1905050),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,MBP
positive regulation of prostaglandin biosynthetic process (GO:0031394),1/5,0.013428510503704937,0.07048071332170557,0,0,94.06603773584904,405.4599145949008,ANXA1
cellular response to nutrient levels (GO:0031669),2/66,0.013743789789728369,0.07173022873403176,0,0,11.948317307692308,51.22444610721821,KCNB1;MTOR
positive regulation of multicellular organismal process (GO:0051240),4/345,0.013983029122014393,0.07257113996844342,0,0,4.599413489736071,19.63908574859944,FGA;BAD;CFL1;MTOR
peptidyl-threonine modification (GO:0018210),2/67,0.01414240690271311,0.07299053340344712,0,0,11.763905325443789,50.09750151432616,MAP2K1;CDK1
negative regulation of cellular catabolic process (GO:0031330),2/69,0.01495456448996044,0.07529396085668136,0,0,11.411595866819749,47.959955677421554,EIF4E;MTOR
carbohydrate homeostasis (GO:0033500),2/70,0.015368047532300751,0.07529396085668136,0,0,11.243212669683258,46.94563829797736,BAD;KCNB1
cellular response to light stimulus (GO:0071482),2/70,0.015368047532300751,0.07529396085668136,0,0,11.243212669683258,46.94563829797736,TP53;CDC25A
wound healing (GO:0042060),2/70,0.015368047532300751,0.07529396085668136,0,0,11.243212669683258,46.94563829797736,ERBB2;RAF1
cellular response to tumor necrosis factor (GO:0071356),3/194,0.015514371253775349,0.07529396085668136,0,0,6.084077610101632,25.346197399122183,CD27;FOXO3;TP53
positive regulation of intracellular signal transduction (GO:1902533),5/546,0.015690761797104467,0.07529396085668136,0,0,3.6600777094571657,15.206463225170449,BAD;ERBB2;CD27;TP53;ESR1
response to metal ion (GO:0010038),2/71,0.01578642864867826,0.07529396085668136,0,0,11.079710144927535,45.96533707599713,FGA;PPP2CB
regulation of collagen fibril organization (GO:1904026),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,RB1
regulation of glucokinase activity (GO:0033131),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,BAD
regulation of thymocyte apoptotic process (GO:0070243),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,TP53
regulation of type B pancreatic cell proliferation (GO:0061469),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,NR4A1
hepatocyte differentiation (GO:0070365),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,ANXA1
response to testosterone (GO:0033574),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,AR
induction of bacterial agglutination (GO:0043152),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,FGA
type B pancreatic cell proliferation (GO:0044342),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,BAD
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,0.016092906355470643,0.07529396085668136,0,0,75.24905660377358,310.73170127161313,BAD
extrinsic apoptotic signaling pathway (GO:0097191),2/72,0.016209679409403953,0.07529396085668136,0,0,10.92087912087912,45.0174660560013,BAD;CD27
response to ionizing radiation (GO:0010212),2/72,0.016209679409403953,0.07529396085668136,0,0,10.92087912087912,45.0174660560013,ANXA1;TP53
positive regulation of protein secretion (GO:0050714),2/72,0.016209679409403953,0.07529396085668136,0,0,10.92087912087912,45.0174660560013,FGA;BAD
positive regulation of secretion by cell (GO:1903532),2/72,0.016209679409403953,0.07529396085668136,0,0,10.92087912087912,45.0174660560013,FGA;KCNB1
regulation of cell population proliferation (GO:0042127),6/764,0.016579696293794455,0.07662954157679129,0,0,3.16424802110818,12.972076660012618,AR;MAP2K1;CHRM1;ERBB2;RAF1;TP53
regulation of peptide hormone secretion (GO:0090276),2/74,0.017070676702069677,0.07850821116941946,0,0,10.616452991452991,43.21313700492695,FGA;KCNB1
generation of neurons (GO:0048699),3/202,0.017263263694291264,0.07881888490720781,0,0,5.837126810523205,23.693916426000204,MAP2K1;ERBB2;DCX
positive regulation of growth (GO:0045927),2/76,0.01795081422272284,0.07881888490720781,0,0,10.328482328482329,41.52173635894564,RPS6KA1;ERBB2
cellular response to UV (GO:0034644),2/77,0.018397990686682745,0.07881888490720781,0,0,10.19025641025641,40.71531033833909,TP53;CDC25A
negative regulation of neurotransmitter secretion (GO:0046929),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,RAP1B
regulation of glial cell differentiation (GO:0045685),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,CDK1
negative regulation of type 2 immune response (GO:0002829),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,ANXA1
regulation of microtubule binding (GO:1904526),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,PPP2CB
regulation of norepinephrine secretion (GO:0014061),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,KCNB1
photoreceptor cell differentiation (GO:0046530),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,DCX
regulation of prostaglandin biosynthetic process (GO:0031392),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,ANXA1
positive regulation of catecholamine secretion (GO:0033605),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,KCNB1
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,MBP
regulation of T-helper 1 cell differentiation (GO:0045625),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,ANXA1
Golgi disassembly (GO:0090166),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,CDK1
response to lead ion (GO:0010288),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,PPP2CB
positive regulation of mitochondrial membrane potential (GO:0010918),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,BAD
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,ANXA1
positive regulation of vesicle fusion (GO:0031340),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,ANXA1
positive regulation of voltage-gated calcium channel activity (GO:1901387),1/7,0.018750240650692064,0.07881888490720781,0,0,62.70440251572328,249.34710980306107,CACNA2D1
negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.018849868567545856,0.07888075630292839,0,0,10.055668016194332,39.933564949004506,RB1;AR
negative regulation of cell population proliferation (GO:0008285),4/379,0.01907831783155569,0.07947873213235532,0,0,4.175146666666667,16.530252292969855,AR;MAP2K1;RAF1;TP53
regulation of cellular response to heat (GO:1900034),2/79,0.019306420224279683,0.0797140639482481,0,0,9.924575424575425,39.175451089946186,CAMK2G;MTOR
regulation of ion transport (GO:0043269),2/79,0.019306420224279683,0.0797140639482481,0,0,9.924575424575425,39.175451089946186,CHRM1;KCNA2
phosphate-containing compound metabolic process (GO:0006796),3/212,0.019598836301390365,0.08016570070075,0,0,5.555023923444976,21.8439377314594,BCKDK;PFKL;MTOR
negative regulation of cell cycle (GO:0045786),2/80,0.01976761811547072,0.08016570070075,0,0,9.796844181459566,38.43997674508189,RB1;NR4A1
negative regulation of cellular component organization (GO:0051129),2/80,0.01976761811547072,0.08016570070075,0,0,9.796844181459566,38.43997674508189,AR;RAF1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.01976761811547072,0.08016570070075,0,0,9.796844181459566,38.43997674508189,FGA;AR
positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.01991293474377998,0.08016570070075,0,0,4.119157894736842,16.13221136859155,AR;MAP2K1;TP53;MTOR
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),2/81,0.02023343481250457,0.08016570070075,0,0,9.672346640701072,37.72620320128746,CHRM1;ESR1
positive regulation of cellular amide metabolic process (GO:0034250),2/81,0.02023343481250457,0.08016570070075,0,0,9.672346640701072,37.72620320128746,ERBB2;MTOR
alpha-beta T cell activation (GO:0046631),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
negative regulation of phospholipase activity (GO:0010519),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
negative regulation of regulated secretory pathway (GO:1903306),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,RAP1B
regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,MTOR
regulation of phospholipase A2 activity (GO:0032429),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
regulation of protein localization to chromatin (GO:1905634),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,RB1
ER overload response (GO:0006983),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,TP53
regulation of T-helper 2 cell differentiation (GO:0045628),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,MTOR
positive regulation of execution phase of apoptosis (GO:1900119),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,TP53
positive regulation of myeloid cell apoptotic process (GO:0033034),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
skeletal muscle tissue regeneration (GO:0043403),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
positive regulation of peptide secretion (GO:0002793),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,FGA
stress-induced premature senescence (GO:0090400),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,TP53
TORC1 signaling (GO:0038202),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,MTOR
myoblast migration (GO:0051451),1/8,0.021400531511072123,0.08016570070075,0,0,53.74393530997305,206.60993448840281,ANXA1
anaphase-promoting complex-dependent catabolic process (GO:0031145),2/84,0.021658325097637533,0.0808055582960051,0,0,9.317073170731708,35.706428544839426,RB1;CDK1
"transcription, DNA-templated (GO:0006351)",3/221,0.02184346920175862,0.08117033155373504,0,0,5.323259579060983,20.35536367879538,CDK7;FOXO3;TP53
glucose homeostasis (GO:0042593),2/86,0.02263084804050612,0.08350703085015163,0,0,9.094322344322345,34.453306781873835,BAD;KCNB1
anoikis (GO:0043276),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,MTOR
negative regulation of exocytosis (GO:0045920),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,ANXA1
regulation of DNA-templated transcription in response to stress (GO:0043620),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,RPS6KA1
regulation of glial cell proliferation (GO:0060251),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,CHRM1
regulation of helicase activity (GO:0051095),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,TP53
"complement activation, classical pathway (GO:0006958)",1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,C1R
regulation of mitotic centrosome separation (GO:0046602),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,NEK2
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,CDK7
plasminogen activation (GO:0031639),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,FGA
endothelial cell chemotaxis (GO:0035767),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,NR4A1
positive regulation of B cell differentiation (GO:0045579),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,CD27
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,PFKL
regulation of vesicle fusion (GO:0031338),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,ANXA1
positive regulation of membrane potential (GO:0045838),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,BAD
kinetochore assembly (GO:0051382),1/9,0.02404379708967068,0.08350703085015163,0,0,47.02358490566038,175.29819860584723,CENPA
apoptotic process (GO:0006915),3/231,0.02449635900239162,0.08350703085015163,0,0,5.087203302373581,18.86961109679792,BAD;RAF1;MTOR
positive regulation of autophagy (GO:0010508),2/90,0.024629159574069845,0.08350703085015163,0,0,8.679195804195805,32.14621536477304,BAD;FOXO3
positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.02513967966881702,0.08350703085015163,0,0,8.58124459809853,31.60736531457828,RB1;VASP
positive regulation of transport (GO:0051050),2/91,0.02513967966881702,0.08350703085015163,0,0,8.58124459809853,31.60736531457828,CHRM1;ANXA1
regulation of gene expression (GO:0010468),7/1079,0.02528656583453605,0.08350703085015163,0,0,2.622221340107971,9.643171827976674,RB1;RBL2;AR;MAP2K1;TP53;ESR1;MTOR
negative regulation of mitotic cell cycle phase transition (GO:1901991),2/92,0.025654523998358342,0.08350703085015163,0,0,8.485470085470086,31.082576873519034,RB1;RBL2
regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.026452903967662384,0.08350703085015163,0,0,4.933917396745932,17.92190893598615,FGA;MAP2K1;ERBB2
Rap protein signal transduction (GO:0032486),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,RAP1B
arachidonate transport (GO:1903963),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,ANXA1
arachidonic acid secretion (GO:0050482),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,ANXA1
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,NEK2
negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MBP
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MBP
cellular response to leucine (GO:0071233),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MTOR
cellular response to leucine starvation (GO:1990253),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MTOR
negative regulation of telomerase activity (GO:0051974),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,TP53
regulation of high voltage-gated calcium channel activity (GO:1901841),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,CACNA2D1
regulation of long-term synaptic depression (GO:1900452),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,KCNB1
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,TP53
positive regulation of cell activation (GO:0050867),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,RPS6KA1
fructose 6-phosphate metabolic process (GO:0006002),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,PFKL
regulation of tau-protein kinase activity (GO:1902947),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,RB1
regulation of type B pancreatic cell development (GO:2000074),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,BAD
granulocyte migration (GO:0097530),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,ANXA1
hematopoietic stem cell differentiation (GO:0060218),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,TP53
response to leucine (GO:0043201),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MTOR
positive regulation of keratinocyte migration (GO:0051549),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MTOR
immunoglobulin mediated immune response (GO:0016064),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,CD27
positive regulation of T cell apoptotic process (GO:0070234),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,TP53
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),1/10,0.026680055532623963,0.08350703085015163,0,0,41.79664570230608,151.46431378315344,MTOR
nucleosome organization (GO:0034728),2/94,0.02669708090688378,0.08350703085015163,0,0,8.300167224080267,30.07317459219205,H3C13;H2BC3
regulation of cell cycle phase transition (GO:1901987),2/95,0.027224741521093776,0.08458790927456895,0,0,8.210504549214226,29.58761315521645,CDK1;TP53
ciliary basal body-plasma membrane docking (GO:0097711),2/95,0.027224741521093776,0.08458790927456895,0,0,8.210504549214226,29.58761315521645,CDK1;NEK2
regulation of neuron apoptotic process (GO:0043523),2/98,0.028832942410493157,0.08582245243465714,0,0,7.952724358974359,28.20224308079517,KCNB1;FOXO3
actin filament depolymerization (GO:0030042),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CFL1
rDNA heterochromatin assembly (GO:0000183),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,H3C13
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CACNA2D1
B cell mediated immunity (GO:0019724),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CD27
regulation of cytoplasmic transport (GO:1903649),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,MAP2K1
negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,ANXA1
nucleus localization (GO:0051647),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,MTOR
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,TP53
positive regulation by host of viral process (GO:0044794),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CFL1
regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,MAP2K1
Golgi inheritance (GO:0048313),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CDK1
positive regulation of integrin activation (GO:0033625),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,RAP1B
positive regulation of leukocyte apoptotic process (GO:2000108),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,ANXA1
humoral immune response mediated by circulating immunoglobulin (GO:0002455),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,C1R
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,TP53
mitochondrial transcription (GO:0006390),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,FOXO3
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.02930932497110778,0.08582245243465714,0,0,37.61509433962264,132.7756240232595,CHRM1
response to UV (GO:0009411),2/99,0.02937733032747144,0.08582245243465714,0,0,7.870340999206978,27.76287956322896,TP53;CDC25A
positive regulation of translation (GO:0045727),2/100,0.02992583628203801,0.08673824045214278,0,0,7.789638932496075,27.33410071093129,ERBB2;MTOR
epithelial cell differentiation (GO:0030855),2/101,0.03047843496490558,0.08673824045214278,0,0,7.710567210567211,26.915553738733543,ANXA1;CDK1
positive regulation of cell growth (GO:0030307),2/102,0.03103510116204576,0.08673824045214278,0,0,7.633076923076923,26.50690091600009,RPS6KA1;ERBB2
intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.03103510116204576,0.08673824045214278,0,0,7.633076923076923,26.50690091600009,BAD;TP53
mitotic sister chromatid segregation (GO:0000070),2/102,0.03103510116204576,0.08673824045214278,0,0,7.633076923076923,26.50690091600009,RB1;CDK1
regulation of transcription by RNA polymerase II (GO:0006357),11/2206,0.03154645003916409,0.08673824045214278,0,0,2.068771520898448,7.150283039618965,RB1;AR;NR4A1;CDK7;RPS6KA1;ERBB2;ERF;CDK1;FOXO3;TP53;ESR1
cellular response to organonitrogen compound (GO:0071417),2/103,0.03159580977714601,0.08673824045214278,0,0,7.557121096725057,26.107818779205395,RAP1B;MTOR
chromatin remodeling (GO:0006338),2/103,0.03159580977714601,0.08673824045214278,0,0,7.557121096725057,26.107818779205395,RB1;ESR1
negative regulation of gene silencing by miRNA (GO:0060965),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,ESR1
carboxylic acid catabolic process (GO:0046395),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,BCKDK
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,ESR1
chromatin assembly or disassembly (GO:0006333),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,TP53
regulation of keratinocyte migration (GO:0051547),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,MTOR
regulation of sister chromatid cohesion (GO:0007063),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,RB1
replicative senescence (GO:0090399),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,TP53
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,RB1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,RB1
positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,RB1
urogenital system development (GO:0001655),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,ANXA1
mitotic G1/S transition checkpoint signaling (GO:0044819),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,TP53
mitotic nuclear membrane disassembly (GO:0007077),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,CDK1
modulation by host of viral process (GO:0044788),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,CFL1
mRNA transcription (GO:0009299),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,TP53
protein localization to condensed chromosome (GO:1903083),1/12,0.03193162350337226,0.08673824045214278,0,0,34.19382504288165,117.768950701619,CDK1
regulation of insulin secretion (GO:0050796),2/104,0.032160535799861306,0.08710535789525117,0,0,7.482654600301659,25.717997405781645,BAD;KCNB1
positive regulation of cell differentiation (GO:0045597),3/258,0.03249339478959638,0.08775105744050885,0,0,4.542329873125721,15.565285571075194,AR;RPS6KA1;MTOR
nucleotide-excision repair (GO:0006289),2/105,0.03272925432536619,0.08787710193140229,0,0,7.409634055265124,25.337139719507565,CDK7;TP53
positive regulation of cellular metabolic process (GO:0031325),2/105,0.03272925432536619,0.08787710193140229,0,0,7.409634055265124,25.337139719507565,CDK1;TP53
regulation of cell cycle process (GO:0010564),2/106,0.03330194056047259,0.08839286508765438,0,0,7.33801775147929,24.964960840949882,NEK2;CDC25C
cellular response to peptide hormone stimulus (GO:0071375),2/106,0.03330194056047259,0.08839286508765438,0,0,7.33801775147929,24.964960840949882,NR4A1;PRKACG
small GTPase mediated signal transduction (GO:0007264),2/106,0.03330194056047259,0.08839286508765438,0,0,7.33801775147929,24.964960840949882,RB1;TP53
positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.03330194056047259,0.08839286508765438,0,0,7.33801775147929,24.964960840949882,MAP2K1;ERBB2
negative regulation of macromolecule biosynthetic process (GO:0010558),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,AR
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,MBP
regulation of membrane repolarization (GO:0060306),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,CACNA2D1
positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,KCNB1
glucan biosynthetic process (GO:0009250),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,GYS2
glycogen biosynthetic process (GO:0005978),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,GYS2
high-density lipoprotein particle assembly (GO:0034380),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,PRKACG
icosanoid secretion (GO:0032309),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,ANXA1
kinetochore organization (GO:0051383),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,CENPA
mitochondrial outer membrane permeabilization (GO:0097345),1/13,0.03454696920988076,0.08915037332216452,0,0,31.342767295597483,105.4820602978719,BAD
activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,BAD
calcium ion import across plasma membrane (GO:0098703),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,CACNA2D1
nuclear membrane disassembly (GO:0051081),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,CDK1
peptidyl-serine dephosphorylation (GO:0070262),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,PPP2CB
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,MTOR
response to X-ray (GO:0010165),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,ANXA1
positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,ANXA1
microvillus organization (GO:0032528),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,RAP1B
protein localization to kinetochore (GO:0034501),1/14,0.03715538012271022,0.09354294887262274,0,0,28.93033381712627,95.25736807729456,CDK1
positive regulation of MAPK cascade (GO:0043410),3/274,0.03780273406569888,0.09421973513671256,0,0,4.270675059691773,13.98805740891038,FGA;MAP2K1;ERBB2
inorganic cation transmembrane transport (GO:0098662),3/274,0.03780273406569888,0.09421973513671256,0,0,4.270675059691773,13.98805740891038,KCNB1;KCNA2;KCNA3
activation of protein kinase activity (GO:0032147),2/114,0.03802332442060594,0.09421973513671256,0,0,6.811126373626373,22.269355743844745,PRKACG;MTOR
positive regulation of cellular component organization (GO:0051130),2/114,0.03802332442060594,0.09421973513671256,0,0,6.811126373626373,22.269355743844745,RB1;AR
cellular response to lectin (GO:1990858),2/115,0.03863062032864137,0.09421973513671256,0,0,6.750510551395507,21.96420398471,PRKACG;RAF1
stimulatory C-type lectin receptor signaling pathway (GO:0002223),2/115,0.03863062032864137,0.09421973513671256,0,0,6.750510551395507,21.96420398471,PRKACG;RAF1
regulation of protein-containing complex assembly (GO:0043254),2/116,0.039241641378425486,0.09421973513671256,0,0,6.690958164642376,21.66543505189019,RB1;RAF1
androgen receptor signaling pathway (GO:0030521),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,AR
calcium ion import into cytosol (GO:1902656),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,CACNA2D1
regulation of dephosphorylation (GO:0035303),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,PPP1R17
cellular response to estrogen stimulus (GO:0071391),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,AR
regulation of extracellular matrix organization (GO:1903053),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,RB1
regulation of integrin activation (GO:0033623),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,RAP1B
regulation of phospholipase C activity (GO:1900274),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,ESR1
photoreceptor cell development (GO:0042461),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,DCX
establishment of spindle localization (GO:0051293),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,CFL1
fibrinolysis (GO:0042730),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,FGA
positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,FGA
positive regulation of protein export from nucleus (GO:0046827),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,TP53
microvillus assembly (GO:0030033),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,RAP1B
mitochondrial RNA metabolic process (GO:0000959),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,FOXO3
myoblast differentiation (GO:0045445),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,RB1
protein kinase A signaling (GO:0010737),1/15,0.03975687424498529,0.09421973513671256,0,0,26.862533692722373,86.63093286520242,PRKACG
regulation of cellular response to stress (GO:0080135),2/118,0.04047476414438527,0.09567698699779624,0,0,6.574933687002653,21.086316017715763,CAMK2G;MTOR
innate immune response activating cell surface receptor signaling pathway (GO:0002220),2/119,0.04109681871092074,0.09690087457473444,0,0,6.518408941485864,20.805617778303198,PRKACG;RAF1
"negative regulation of transcription, DNA-templated (GO:0045892)",6/948,0.04172840484243827,0.09738741386322518,0,0,2.5217622080679405,8.010562274125574,RB1;AR;ERF;FOXO3;TP53;ESR1
positive regulation of programmed cell death (GO:0043068),3/286,0.04205955507728984,0.09738741386322518,0,0,4.087092080648514,12.950640697039171,BAD;FOXO3;TP53
regulation of cellular carbohydrate metabolic process (GO:0010675),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,BCKDK
regulation of ERBB signaling pathway (GO:1901184),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,ERBB2
regulation of establishment of cell polarity (GO:2000114),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,RAP1B
cellular response to corticosteroid stimulus (GO:0071384),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,ANXA1
regulation of hormone secretion (GO:0046883),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,ANXA1
regulation of interleukin-1 production (GO:0032652),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,ANXA1
positive regulation of vasoconstriction (GO:0045907),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,FGA
mitotic sister chromatid cohesion (GO:0007064),1/16,0.04235146953793646,0.09738741386322518,0,0,25.07044025157233,79.26651858378708,RB1
regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.043621112707563775,0.1000592930995722,0,0,6.301652892561983,19.738125472583143,CFL1;ERBB2
cellular response to oxidative stress (GO:0034599),2/125,0.04490458082246664,0.10011631143013232,0,0,6.198561601000625,19.235472231305938,FOXO3;TP53
regulation of protein secretion (GO:0050708),2/125,0.04490458082246664,0.10011631143013232,0,0,6.198561601000625,19.235472231305938,FGA;KCNB1
negative regulation of ATPase activity (GO:0032780),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,TP53
activation of protein kinase A activity (GO:0034199),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,PRKACG
negative regulation of insulin secretion (GO:0046676),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,KCNB1
cellular response to gamma radiation (GO:0071480),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,TP53
regulation of Golgi organization (GO:1903358),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,MAP2K1
regulation of leukocyte migration (GO:0002685),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,ANXA1
gliogenesis (GO:0042063),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,ANXA1
positive regulation of regulated secretory pathway (GO:1903307),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,KCNB1
membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,CACNA2D1
positive regulation of telomere capping (GO:1904355),1/17,0.04493918392504326,0.10011631143013232,0,0,23.50235849056604,72.91477862029602,NEK2
negative regulation of cell growth (GO:0030308),2/126,0.0455515647353355,0.10099619006951475,0,0,6.148263027295285,18.99143301565767,RB1;TP53
negative regulation of growth (GO:0045926),2/126,0.0455515647353355,0.10099619006951475,0,0,6.148263027295285,18.99143301565767,RB1;TP53
negative regulation of fibroblast proliferation (GO:0048147),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,TP53
regulation of B cell differentiation (GO:0045577),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,CD27
negative regulation of interleukin-8 production (GO:0032717),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,ANXA1
cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,NR4A1
negative regulation of peptide hormone secretion (GO:0090278),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,KCNB1
regulation of early endosome to late endosome transport (GO:2000641),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,MAP2K1
regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,RAP1B
cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,ANXA1
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,ANXA1
regulation of transcription by RNA polymerase I (GO:0006356),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,ERBB2
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,CACNA2D1
release of cytochrome c from mitochondria (GO:0001836),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,BAD
positive regulation of extracellular matrix organization (GO:1903055),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,RB1
leukocyte tethering or rolling (GO:0050901),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,ADD2
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.04752003528742647,0.10171915387562024,0,0,22.11875693673696,67.38709029166962,MTOR
actin filament capping (GO:0051693),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,ADD2
barbed-end actin filament capping (GO:0051016),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,ADD2
cardiac muscle cell contraction (GO:0086003),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,CACNA2D1
cellular response to glucagon stimulus (GO:0071377),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,PRKACG
negative regulation of RNA metabolic process (GO:0051253),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,ESR1
cellular response to interleukin-7 (GO:0098761),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,H3C13
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,BAD
pore complex assembly (GO:0046931),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,BAD
regulation of synaptic vesicle exocytosis (GO:2000300),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,RAP1B
response to fatty acid (GO:0070542),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,FOXO3
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,H3C13
leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.05009404144634451,0.10428146722672012,0,0,20.88888888888889,62.53826707779693,ADD2
regulation of cell motility (GO:2000145),2/133,0.050176335683900855,0.10428146722672012,0,0,5.817674691720494,17.40771465255104,ERBB2;RAF1
positive regulation of apoptotic process (GO:0043065),3/310,0.05126662433231675,0.10630958483196934,0,0,3.7629814140639968,11.178746597147123,BAD;FOXO3;TP53
branched-chain amino acid catabolic process (GO:0009083),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,BCKDK
branched-chain amino acid metabolic process (GO:0009081),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,BCKDK
regulation of protein localization to cell periphery (GO:1904375),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,AR
positive regulation of embryonic development (GO:0040019),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,CFL1
positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,BAD
positive regulation of hormone secretion (GO:0046887),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,FGA
positive regulation of lymphocyte differentiation (GO:0045621),1/20,0.05266122021570595,0.10752148039646336,0,0,19.788480635551142,58.25483230121243,CD27
cilium assembly (GO:0060271),3/314,0.05288944485239969,0.10775064532429676,0,0,3.7138263665594855,10.916983830264504,DCX;CDK1;NEK2
regulation of cellular component organization (GO:0051128),2/139,0.05426992234060185,0.10985194110777396,0,0,5.561201572150477,16.204146400763,RAP1B;MTOR
calcium ion transport into cytosol (GO:0060402),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,CACNA2D1
cellular response to estradiol stimulus (GO:0071392),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,ESR1
cellular response to steroid hormone stimulus (GO:0071383),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,AR
response to glucagon (GO:0033762),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,PRKACG
positive regulation of immune system process (GO:0002684),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,ANXA1
sensory perception of pain (GO:0019233),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,KCNA2
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,TP53
positive regulation of phosphatase activity (GO:0010922),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,MTOR
positive regulation of transcription regulatory region DNA binding (GO:2000679),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,RB1
protein localization to chromatin (GO:0071168),1/21,0.05522158934050639,0.10985194110777396,0,0,18.79811320754717,54.4468793612393,ESR1
positive regulation of cellular catabolic process (GO:0031331),2/141,0.05566013819889164,0.11048775296318449,0,0,5.480630879911455,15.830753190036184,BAD;FOXO3
cellular response to oxygen-containing compound (GO:1901701),3/323,0.05663131903340279,0.11205246285038269,0,0,3.6077205882352943,10.358462484909642,RAP1B;ESR1;MTOR
negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.05706291045370099,0.11205246285038269,0,0,5.4023458810692855,15.470162676234262,RB1;ESR1
neuron development (GO:0048666),2/143,0.05706291045370099,0.11205246285038269,0,0,5.4023458810692855,15.470162676234262,RB1;DCX
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,CACNA2D1
regulation of chromosome organization (GO:0033044),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,RB1
negative regulation of phosphate metabolic process (GO:0045936),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,TP53
regulation of execution phase of apoptosis (GO:1900117),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,TP53
negative regulation of small molecule metabolic process (GO:0062014),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,BCKDK
neuronal action potential (GO:0019228),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,KCNA2
peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,PPP2CB
positive regulation of translational initiation (GO:0045948),1/22,0.05777516652888407,0.11205246285038269,0,0,17.902066486972146,51.04230466405881,MTOR
positive regulation of cytosolic calcium ion concentration (GO:0007204),2/147,0.059905445116051205,0.11578328432737792,0,0,5.252254641909814,14.785033131037055,CACNA2D1;ESR1
regulation of calcium ion transmembrane transport (GO:1903169),1/23,0.06032196944504943,0.11578328432737792,0,0,17.087478559176674,47.98264634686218,CACNA2D1
blood vessel endothelial cell migration (GO:0043534),1/23,0.06032196944504943,0.11578328432737792,0,0,17.087478559176674,47.98264634686218,NR4A1
regulation of protein export from nucleus (GO:0046825),1/23,0.06032196944504943,0.11578328432737792,0,0,17.087478559176674,47.98264634686218,TP53
regulation of telomere capping (GO:1904353),1/23,0.06032196944504943,0.11578328432737792,0,0,17.087478559176674,47.98264634686218,NEK2
positive regulation of transferase activity (GO:0051347),2/148,0.06062366242637377,0.11612243792598193,0,0,5.216016859852476,14.620860343032804,ERBB2;NEK2
regulation of cell size (GO:0008361),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,MTOR
canonical glycolysis (GO:0061621),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,PFKL
DNA packaging (GO:0006323),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,TP53
establishment of mitotic spindle orientation (GO:0000132),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,CENPA
glucose catabolic process to pyruvate (GO:0061718),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,PFKL
response to gamma radiation (GO:0010332),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,TP53
heterochromatin assembly (GO:0031507),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,H3C13
positive regulation of neuron apoptotic process (GO:0043525),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,FOXO3
positive regulation of phospholipase activity (GO:0010518),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,ESR1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,TP53
protein insertion into mitochondrial membrane (GO:0051204),1/24,0.06286201570363556,0.11773954150943032,0,0,16.343724364232976,45.22003200693963,BAD
regulation of dopamine secretion (GO:0014059),1/25,0.06539532289924611,0.12150450994679927,0,0,15.66194968553459,42.71490645721221,KCNA2
cellular response to hexose stimulus (GO:0071331),1/25,0.06539532289924611,0.12150450994679927,0,0,15.66194968553459,42.71490645721221,KCNB1
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.06539532289924611,0.12150450994679927,0,0,15.66194968553459,42.71490645721221,PFKL
positive regulation of lipid metabolic process (GO:0045834),1/25,0.06539532289924611,0.12150450994679927,0,0,15.66194968553459,42.71490645721221,MTOR
negative regulation of macroautophagy (GO:0016242),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,MTOR
cellular response to drug (GO:0035690),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,TP53
regulation of mitotic metaphase/anaphase transition (GO:0030071),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,RB1
DNA geometric change (GO:0032392),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,ANXA1
endothelial cell development (GO:0001885),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,RAP1B
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,ANXA1
positive regulation of interleukin-2 production (GO:0032743),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,ANXA1
TOR signaling (GO:0031929),1/26,0.0679219085557706,0.12421152174864349,0,0,15.034716981132076,40.43431729208938,MTOR
supramolecular fiber organization (GO:0097435),3/351,0.06905514922030606,0.12584696742472387,0,0,3.312711291413117,8.854379810647949,FGA;MARCKS;H3C13
positive regulation of protein kinase B signaling (GO:0051897),2/161,0.07022528984281871,0.12584696742472387,0,0,4.78640541848089,12.71291669309357,ERBB2;ESR1
negative regulation of catalytic activity (GO:0043086),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,TP53
negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,FGA
regulation of cell junction assembly (GO:1901888),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,RAP1B
cellular senescence (GO:0090398),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,MAP2K1
entrainment of circadian clock by photoperiod (GO:0043153),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,TP53
regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,RB1
regulation of vasculature development (GO:1901342),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,ERBB2
positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,FOXO3
response to glucocorticoid (GO:0051384),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,ANXA1
positive regulation of mitotic cell cycle (GO:0045931),1/27,0.0704417901623858,0.12584696742472387,0,0,14.455732946298983,38.35060533159885,EIF4E
cellular response to acid chemical (GO:0071229),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,MTOR
cellular response to epidermal growth factor stimulus (GO:0071364),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,ERBB2
cytosolic calcium ion transport (GO:0060401),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,CACNA2D1
regulation of multicellular organismal development (GO:2000026),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,CDK1
regulation of phosphatase activity (GO:0010921),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,PPP1R17
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,CAMK2G
regulation of postsynapse organization (GO:0099175),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,CFL1
photoperiodism (GO:0009648),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,TP53
regulation of small molecule metabolic process (GO:0062012),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,BCKDK
glycogen metabolic process (GO:0005977),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,GYS2
macromolecule catabolic process (GO:0009057),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,MTOR
positive regulation of response to wounding (GO:1903036),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,ANXA1
protein depolymerization (GO:0051261),1/28,0.07295498516431843,0.12715793849465634,0,0,13.919636617749823,36.44039305811433,CFL1
regulation of neuron projection development (GO:0010975),2/165,0.07327446891915697,0.1274756210222787,0,0,4.668003775365738,12.200028778679457,CFL1;CAMK2G
regulation of MAPK cascade (GO:0043408),2/166,0.07404344076426465,0.12857262891589133,0,0,4.639305816135084,12.076592375548062,MAP2K1;ERBB2
"regulation of transcription, DNA-templated (GO:0006355)",10/2244,0.075357497548038,0.12956166826883417,0,0,1.8019044518596887,4.658845323481672,RB1;AR;NR4A1;MAP2K1;RPS6KA1;ERBB2;ERF;FOXO3;TP53;ESR1
negative regulation of transferase activity (GO:0051348),1/29,0.07546151096326235,0.12956166826883417,0,0,13.421832884097036,34.683795119411634,TP53
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/29,0.07546151096326235,0.12956166826883417,0,0,13.421832884097036,34.683795119411634,CDK7
establishment of endothelial barrier (GO:0061028),1/29,0.07546151096326235,0.12956166826883417,0,0,13.421832884097036,34.683795119411634,RAP1B
establishment of mitotic spindle localization (GO:0040001),1/29,0.07546151096326235,0.12956166826883417,0,0,13.421832884097036,34.683795119411634,CENPA
glycolytic process (GO:0006096),1/29,0.07546151096326235,0.12956166826883417,0,0,13.421832884097036,34.683795119411634,PFKL
cellular protein-containing complex assembly (GO:0034622),2/168,0.07558926178870627,0.12956166826883417,0,0,4.582947173308619,11.835190890705748,FGA;CENPA
"negative regulation of gene expression, epigenetic (GO:0045814)",1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,H3C13
cardiac muscle cell action potential (GO:0086001),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,CACNA2D1
CENP-A containing chromatin organization (GO:0061641),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,CENPA
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,CENPA
regulation of protein localization to membrane (GO:1905475),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,AR
establishment of spindle orientation (GO:0051294),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,CENPA
positive regulation of endopeptidase activity (GO:0010950),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,MBP
regulation of vasoconstriction (GO:0019229),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,FGA
positive regulation of phosphate metabolic process (GO:0045937),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,AR
maintenance of blood-brain barrier (GO:0035633),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,MBP
termination of RNA polymerase I transcription (GO:0006363),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,CDK7
primary neural tube formation (GO:0014020),1/30,0.07796138492038997,0.130733080489246,0,0,12.958360442420298,33.06379625497651,VASP
positive regulation of protein phosphorylation (GO:0001934),3/371,0.0786273577476698,0.13151678995127705,0,0,3.1294757033248084,7.958368051410858,ERBB2;RAF1;TP53
positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.07871187859301404,0.13151678995127705,0,0,4.47420814479638,11.373263504081194,FGA;MAP2K1
cation transport (GO:0006812),2/174,0.0802883718469711,0.13193907197336951,0,0,4.421735241502684,11.152193215564584,KCNA2;KCNA3
neuron differentiation (GO:0030182),2/174,0.0802883718469711,0.13193907197336951,0,0,4.421735241502684,11.152193215564584,MAP2K1;ERBB2
activation of protein kinase B activity (GO:0032148),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,MTOR
regulation of calcium ion-dependent exocytosis (GO:0017158),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,KCNB1
regulation of cellular component size (GO:0032535),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,MTOR
cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,CACNA2D1
cellular response to cAMP (GO:0071320),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,RAP1B
peptide cross-linking (GO:0018149),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,ANXA1
renal water homeostasis (GO:0003091),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,PRKACG
tube closure (GO:0060606),1/31,0.08045462435891494,0.13193907197336951,0,0,12.525786163522012,31.56575680442027,VASP
7-methylguanosine mRNA capping (GO:0006370),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CDK7
7-methylguanosine RNA capping (GO:0009452),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CDK7
negative regulation of DNA biosynthetic process (GO:2000279),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,TP53
aortic valve morphogenesis (GO:0003180),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,RB1
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,ANXA1
regulation of cell morphogenesis (GO:0022604),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CFL1
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CFL1
cellular response to glucose stimulus (GO:0071333),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,KCNB1
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,ESR1
chromatin remodeling at centromere (GO:0031055),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CENPA
ERBB2 signaling pathway (GO:0038128),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,ERBB2
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,RB1
response to amino acid (GO:0043200),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,MTOR
hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,TP53
liver development (GO:0001889),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,ANXA1
transcription initiation from RNA polymerase I promoter (GO:0006361),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,CDK7
positive regulation of telomere maintenance (GO:0032206),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,NEK2
mitochondrial membrane organization (GO:0007006),1/32,0.08294124653654229,0.13193907197336951,0,0,12.121119902617163,30.177016409267804,BAD
positive regulation of cellular biosynthetic process (GO:0031328),2/180,0.08507680254469614,0.1335965633167216,0,0,4.271391529818496,10.52556672861556,ERBB2;MTOR
actin filament bundle assembly (GO:0051017),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,ADD2
actin filament bundle organization (GO:0061572),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,ADD2
apoptotic cell clearance (GO:0043277),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,ANXA1
apoptotic mitochondrial changes (GO:0008637),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,BAD
signal transduction by p53 class mediator (GO:0072331),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,TP53
positive regulation of organelle organization (GO:0010638),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,ANXA1
lytic vacuole organization (GO:0080171),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,MTOR
positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,NEK2
mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.08542126868690271,0.1335965633167216,0,0,11.741745283018869,28.88657396987172,CDK1
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,FGA
axoneme assembly (GO:0035082),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,DCX
cellular response to amino acid stimulus (GO:0071230),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,MTOR
regulation of glucose metabolic process (GO:0010906),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,BCKDK
neural tube closure (GO:0001843),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,VASP
organelle disassembly (GO:1903008),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,CDK1
phosphatidylinositol 3-kinase signaling (GO:0014065),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,ERBB2
positive regulation of DNA binding (GO:0043388),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,RB1
response to steroid hormone (GO:0048545),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,AR
sister chromatid segregation (GO:0000819),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,RB1
positive regulation of protein dephosphorylation (GO:0035307),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,MTOR
transcription by RNA polymerase I (GO:0006360),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,CDK7
positive regulation of telomerase activity (GO:0051973),1/34,0.08789470799411693,0.1345208957603536,0,0,11.385363064608349,27.684827361193253,NEK2
cellular response to amyloid-beta (GO:1904646),1/35,0.09036158158919066,0.13716651845810152,0,0,11.049944506104328,26.563360328124432,CACNA2D1
cellular response to hydrogen peroxide (GO:0070301),1/35,0.09036158158919066,0.13716651845810152,0,0,11.049944506104328,26.563360328124432,ANXA1
regulation of lipid biosynthetic process (GO:0046890),1/35,0.09036158158919066,0.13716651845810152,0,0,11.049944506104328,26.563360328124432,MTOR
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.09036158158919066,0.13716651845810152,0,0,11.049944506104328,26.563360328124432,ANXA1
positive regulation of lipid biosynthetic process (GO:0046889),1/35,0.09036158158919066,0.13716651845810152,0,0,11.049944506104328,26.563360328124432,MTOR
regulation of mitotic cell cycle phase transition (GO:1901990),2/188,0.09159348184787752,0.13863593443235292,0,0,4.086021505376344,9.76720606565563,CDK1;NEK2
activation of adenylate cyclase activity (GO:0007190),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,RAF1
aortic valve development (GO:0003176),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,RB1
regulation of microtubule-based process (GO:0032886),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,ERBB2
regulation of osteoclast differentiation (GO:0045670),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,MTOR
platelet aggregation (GO:0070527),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,FGA
positive regulation of mitotic nuclear division (GO:0045840),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,RB1
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,TP53
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,FGA
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.09282190658441714,0.13863593443235292,0,0,10.733692722371968,25.514766917792368,NEK2
negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,FGA
regulation of erythrocyte differentiation (GO:0045646),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,FOXO3
centromere complex assembly (GO:0034508),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,CENPA
glutamate receptor signaling pathway (GO:0007215),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,KCNB1
positive regulation of exocytosis (GO:0045921),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,FGA
positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0952757000126654,0.14094128234357667,0,0,10.435010482180294,24.53250600399325,FOXO3
regulation of programmed cell death (GO:0043067),2/194,0.09657508182792995,0.1425190697140581,0,0,3.95713141025641,9.2495355708988,RAF1;TP53
regulation of apoptotic signaling pathway (GO:2001233),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,RB1
regulation of cell communication (GO:0010646),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,ANXA1
regulation of phosphoprotein phosphatase activity (GO:0043666),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,MTOR
positive regulation of cell development (GO:0010720),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,BAD
response to cAMP (GO:0051591),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,RAP1B
positive regulation of insulin secretion (GO:0032024),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,BAD
histone exchange (GO:0043486),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,CENPA
lysosome organization (GO:0007040),1/38,0.09772297891050057,0.1425190697140581,0,0,10.152473227944926,23.610780056259,MTOR
regulation of cellular component biogenesis (GO:0044087),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,RAP1B
negative regulation of protein secretion (GO:0050709),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,KCNB1
regulation of exit from mitosis (GO:0007096),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,NEK2
negative regulation of secretion by cell (GO:1903531),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,ANXA1
cellular response to ketone (GO:1901655),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,AR
regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,CACNA2D1
DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,CENPA
endothelial cell migration (GO:0043542),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,NR4A1
response to peptide (GO:1901652),1/39,0.10016376022168876,0.14404354991632948,0,0,9.88480635551142,22.74443362032508,ANXA1
negative regulation of blood coagulation (GO:0030195),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,FGA
negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,ERBB2
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,ESR1
bone development (GO:0060348),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,TP53
response to organonitrogen compound (GO:0010243),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,MTOR
stem cell differentiation (GO:0048863),1/40,0.10259806088452916,0.1461865008615454,0,0,9.630865989356556,21.928867853316252,TP53
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,MBP
carbohydrate catabolic process (GO:0016052),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,PFKL
regulation of mitochondrial membrane potential (GO:0051881),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,BAD
response to growth factor (GO:0070848),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,ERBB2
keratinocyte differentiation (GO:0030216),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,ANXA1
T cell differentiation (GO:0030217),1/41,0.10502589777658966,0.14828124473320942,0,0,9.389622641509431,21.159968270478103,ANXA1
regulation of inflammatory response (GO:0050727),2/206,0.10676411589952754,0.1503291118885583,0,0,3.722096530920061,8.326826476146689,RB1;ANXA1
calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.10744728772228491,0.1503291118885583,0,0,9.160147261849977,20.434043374832477,CACNA2D1
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.10744728772228491,0.1503291118885583,0,0,9.160147261849977,20.434043374832477,FGA
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.10744728772228491,0.1503291118885583,0,0,9.160147261849977,20.434043374832477,MTOR
mitochondrial gene expression (GO:0140053),1/42,0.10744728772228491,0.1503291118885583,0,0,9.160147261849977,20.434043374832477,FOXO3
monocyte chemotaxis (GO:0002548),1/42,0.10744728772228491,0.1503291118885583,0,0,9.160147261849977,20.434043374832477,ANXA1
regulation of protein kinase B signaling (GO:0051896),2/207,0.10762610564887289,0.15035286037263595,0,0,3.70375234521576,8.256004882432496,ERBB2;ESR1
cellular glucose homeostasis (GO:0001678),1/43,0.10986224753115834,0.1527178565957883,0,0,8.941599281221922,19.747772315999956,KCNB1
positive regulation of phospholipase C activity (GO:0010863),1/43,0.10986224753115834,0.1527178565957883,0,0,8.941599281221922,19.747772315999956,ESR1
substantia nigra development (GO:0021762),1/43,0.10986224753115834,0.1527178565957883,0,0,8.941599281221922,19.747772315999956,MBP
regulation of nucleic acid-templated transcription (GO:1903506),3/430,0.10997658349040083,0.1527178565957883,0,0,2.6889378702300597,5.935797579015244,RB1;TP53;ESR1
negative regulation of inflammatory response (GO:0050728),2/212,0.11196436584919328,0.15428930117118894,0,0,3.614652014652015,7.914550312758943,RB1;PRKACG
antibacterial humoral response (GO:0019731),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,FGA
regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,FGA
neurogenesis (GO:0022008),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,ANXA1
positive regulation of biosynthetic process (GO:0009891),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,MTOR
response to amyloid-beta (GO:1904645),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,CACNA2D1
homotypic cell-cell adhesion (GO:0034109),1/44,0.11227079396310412,0.15428930117118894,0,0,8.733216322948662,19.098160081121275,FGA
regulation of intracellular signal transduction (GO:1902531),3/437,0.11398033631764314,0.15640728572982346,0,0,2.644619137977772,5.743396958958729,CDK1;TP53;MTOR
cellular response to radiation (GO:0071478),1/45,0.1146729436907043,0.15666347748332984,0,0,8.534305317324185,18.482498984150983,TP53
microtubule bundle formation (GO:0001578),1/45,0.1146729436907043,0.15666347748332984,0,0,8.534305317324185,18.482498984150983,DCX
mitotic G2/M transition checkpoint (GO:0044818),1/45,0.1146729436907043,0.15666347748332984,0,0,8.534305317324185,18.482498984150983,CDK1
regulation of fibroblast proliferation (GO:0048145),1/46,0.11706871342498994,0.15946749966541884,0,0,8.344234800838574,17.89833543767599,TP53
positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.11706871342498994,0.15946749966541884,0,0,8.344234800838574,17.89833543767599,TP53
cellular response to lipid (GO:0071396),2/219,0.1181143172504817,0.16065622361009882,0,0,3.496809641970932,7.469543235084247,AR;ESR1
negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.11945811977341562,0.16130318789171966,0,0,8.162428219852337,17.34344121433972,RB1
regulation of protein localization to nucleus (GO:1900180),1/47,0.11945811977341562,0.16130318789171966,0,0,8.162428219852337,17.34344121433972,CDK1
positive regulation of cell-cell adhesion (GO:0022409),1/47,0.11945811977341562,0.16130318789171966,0,0,8.162428219852337,17.34344121433972,FGA
regulation of wound healing (GO:0061041),1/47,0.11945811977341562,0.16130318789171966,0,0,8.162428219852337,17.34344121433972,ANXA1
positive regulation of neuron death (GO:1901216),1/47,0.11945811977341562,0.16130318789171966,0,0,8.162428219852337,17.34344121433972,FOXO3
cellular response to ionizing radiation (GO:0071479),1/48,0.1218411792961756,0.16357002249443228,0,0,7.988358089120835,16.815788479202197,TP53
regulation of interleukin-2 production (GO:0032663),1/48,0.1218411792961756,0.16357002249443228,0,0,7.988358089120835,16.815788479202197,ANXA1
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1218411792961756,0.16357002249443228,0,0,7.988358089120835,16.815788479202197,ANXA1
myelination (GO:0042552),1/48,0.1218411792961756,0.16357002249443228,0,0,7.988358089120835,16.815788479202197,MBP
cellular response to mechanical stimulus (GO:0071260),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,BAD
positive regulation of actin filament polymerization (GO:0030838),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,VASP
regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,MAP2K1
response to hydrogen peroxide (GO:0042542),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,ANXA1
positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,TP53
mitotic cytokinesis (GO:0000281),1/49,0.12421790857292912,0.16532727373101885,0,0,7.821540880503145,16.313528042717785,CENPA
actin polymerization or depolymerization (GO:0008154),1/50,0.1265883240687765,0.16728385926016123,0,0,7.661532537543319,15.834970375184442,CFL1
regulation of complement activation (GO:0030449),1/50,0.1265883240687765,0.16728385926016123,0,0,7.661532537543319,15.834970375184442,C1R
neuron migration (GO:0001764),1/50,0.1265883240687765,0.16728385926016123,0,0,7.661532537543319,15.834970375184442,DCX
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1265883240687765,0.16728385926016123,0,0,7.661532537543319,15.834970375184442,FGA
positive regulation of ion transport (GO:0043270),1/50,0.1265883240687765,0.16728385926016123,0,0,7.661532537543319,15.834970375184442,CHRM1
DNA duplex unwinding (GO:0032508),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,ANXA1
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,FGA
sensory perception (GO:0007600),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,KCNA2
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,TP53
mitotic nuclear membrane organization (GO:0101024),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,CDK1
mitotic nuclear membrane reassembly (GO:0007084),1/51,0.1289524422762036,0.16896589404032883,0,0,7.507924528301887,15.378568956697888,CDK1
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.1313102795600359,0.1708504897916994,0,0,7.360340362560119,14.942905667794824,RAF1
regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.1313102795600359,0.1708504897916994,0,0,7.360340362560119,14.942905667794824,NEK2
response to peptide hormone (GO:0043434),1/52,0.1313102795600359,0.1708504897916994,0,0,7.360340362560119,14.942905667794824,ANXA1
signal transduction in response to DNA damage (GO:0042770),1/52,0.1313102795600359,0.1708504897916994,0,0,7.360340362560119,14.942905667794824,TP53
sprouting angiogenesis (GO:0002040),1/52,0.1313102795600359,0.1708504897916994,0,0,7.360340362560119,14.942905667794824,NR4A1
regulation of immune effector process (GO:0002697),1/53,0.13366185231401212,0.17270077997179034,0,0,7.218432510885341,14.526677903865671,C1R
epidermal cell differentiation (GO:0009913),1/53,0.13366185231401212,0.17270077997179034,0,0,7.218432510885341,14.526677903865671,ANXA1
positive regulation of B cell activation (GO:0050871),1/53,0.13366185231401212,0.17270077997179034,0,0,7.218432510885341,14.526677903865671,CD27
positive regulation of chemokine production (GO:0032722),1/53,0.13366185231401212,0.17270077997179034,0,0,7.218432510885341,14.526677903865671,MBP
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.13366185231401212,0.17270077997179034,0,0,7.218432510885341,14.526677903865671,CD27
regulation of cellular amino acid metabolic process (GO:0006521),1/54,0.13600717688085265,0.17431620357175642,0,0,7.081879672481311,14.128687210183031,BCKDK
regulation of humoral immune response (GO:0002920),1/54,0.13600717688085265,0.17431620357175642,0,0,7.081879672481311,14.128687210183031,C1R
nuclear membrane reassembly (GO:0031468),1/54,0.13600717688085265,0.17431620357175642,0,0,7.081879672481311,14.128687210183031,CDK1
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.13600717688085265,0.17431620357175642,0,0,7.081879672481311,14.128687210183031,H3C13
regulation of proteolysis (GO:0030162),1/54,0.13600717688085265,0.17431620357175642,0,0,7.081879672481311,14.128687210183031,BAD
positive regulation of cell population proliferation (GO:0008284),3/474,0.1360379414311339,0.17431620357175642,0,0,2.432246784063944,4.8518980590806216,AR;BAD;ERBB2
pyruvate metabolic process (GO:0006090),1/55,0.13834626953351245,0.1765435225228476,0,0,6.950384346610762,13.747829218668,PFKL
regulation of gene silencing by RNA (GO:0060966),1/55,0.13834626953351245,0.1765435225228476,0,0,6.950384346610762,13.747829218668,H3C13
regulation of posttranscriptional gene silencing (GO:0060147),1/55,0.13834626953351245,0.1765435225228476,0,0,6.950384346610762,13.747829218668,H3C13
negative regulation of metabolic process (GO:0009892),1/56,0.14067914651365568,0.17853951791145645,0,0,6.823670668953688,13.383084716807277,RB1
peptidyl-tyrosine modification (GO:0018212),1/56,0.14067914651365568,0.17853951791145645,0,0,6.823670668953688,13.383084716807277,ERBB2
Rho protein signal transduction (GO:0007266),1/56,0.14067914651365568,0.17853951791145645,0,0,6.823670668953688,13.383084716807277,CFL1
mitochondrial transport (GO:0006839),1/56,0.14067914651365568,0.17853951791145645,0,0,6.823670668953688,13.383084716807277,BAD
cellular response to cytokine stimulus (GO:0071345),3/482,0.1409927376865112,0.17869338787280886,0,0,2.3906422694338696,4.683380316663292,ANXA1;FOXO3;TP53
positive regulation of DNA-binding transcription factor activity (GO:0051091),2/246,0.142579809887708,0.18045864221482388,0,0,3.1056116015132407,6.049276013565581,AR;ESR1
regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.1430058240466105,0.1805059925805722,0,0,6.701482479784366,13.033511707426957,TP53
positive regulation of proteolysis (GO:0045862),1/57,0.1430058240466105,0.1805059925805722,0,0,6.701482479784366,13.033511707426957,BAD
fat cell differentiation (GO:0045444),1/58,0.14532631826774292,0.1831860918191766,0,0,6.583581595498179,12.698238337093317,NR4A1
protein polymerization (GO:0051258),1/59,0.14764064534934584,0.18559967460019253,0,0,6.469746258945999,12.376456572299608,FGA
regulation of secretion by cell (GO:1903530),1/59,0.14764064534934584,0.18559967460019253,0,0,6.469746258945999,12.376456572299608,ANXA1
positive regulation of phosphorylation (GO:0042327),2/253,0.14909221180152404,0.18717116859948085,0,0,3.0179282868525896,5.74369182143534,AR;ERBB2
pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1522508622365813,0.1906213625576604,0,0,6.253459119496855,11.770421525608556,FGA
positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.1522508622365813,0.1906213625576604,0,0,6.253459119496855,11.770421525608556,NEK2
negative regulation of kinase activity (GO:0033673),1/62,0.15454678410953343,0.19297575596472652,0,0,6.150634085988246,11.484823277475584,RB1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.15454678410953343,0.19297575596472652,0,0,6.150634085988246,11.484823277475584,BAD
actin cytoskeleton reorganization (GO:0031532),1/63,0.15683660288249493,0.1953099250373161,0,0,6.051125989044431,11.21001805928369,ANXA1
cellular response to reactive oxygen species (GO:0034614),1/63,0.15683660288249493,0.1953099250373161,0,0,6.051125989044431,11.21001805928369,ANXA1
negative regulation of cell cycle process (GO:0010948),1/64,0.1591203344708972,0.19736020123292855,0,0,5.954776879305181,10.945442883265992,NEK2
regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.1591203344708972,0.19736020123292855,0,0,5.954776879305181,10.945442883265992,AR
protein catabolic process (GO:0030163),1/64,0.1591203344708972,0.19736020123292855,0,0,5.954776879305181,10.945442883265992,MTOR
negative regulation of signal transduction (GO:0009968),2/267,0.1622944933964656,0.20102877915375536,0,0,2.856458635703919,5.194020804022266,RB1;ERBB2
ERBB signaling pathway (GO:0038127),1/66,0.16366959960719915,0.20192437986067463,0,0,5.770972423802612,10.444914844508016,ERBB2
positive regulation of cell cycle (GO:0045787),1/66,0.16366959960719915,0.20192437986067463,0,0,5.770972423802612,10.444914844508016,EIF4E
positive regulation of T cell proliferation (GO:0042102),1/66,0.16366959960719915,0.20192437986067463,0,0,5.770972423802612,10.444914844508016,ANXA1
regulation of gene silencing by miRNA (GO:0060964),1/67,0.1659351647622365,0.2041771762438645,0,0,5.683247570040023,10.208011388204676,H3C13
transcription elongation from RNA polymerase II promoter (GO:0006368),1/67,0.1659351647622365,0.2041771762438645,0,0,5.683247570040023,10.208011388204676,CDK7
regulation of myeloid cell differentiation (GO:0045637),1/68,0.16819470601465605,0.20613836660635285,0,0,5.598141368628555,9.979431577576143,H3C13
interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.16819470601465605,0.20613836660635285,0,0,5.598141368628555,9.979431577576143,CAMK2G
positive regulation of protein localization to nucleus (GO:1900182),1/68,0.16819470601465605,0.20613836660635285,0,0,5.598141368628555,9.979431577576143,CDK1
cell chemotaxis (GO:0060326),1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,NR4A1
peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,ERBB2
"DNA-templated transcription, elongation (GO:0006354)",1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,CDK7
positive regulation of MAP kinase activity (GO:0043406),1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,ERBB2
positive regulation of protein polymerization (GO:0032273),1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,VASP
positive regulation of protein transport (GO:0051222),1/69,0.17044823907414808,0.2072597043192193,0,0,5.5155382907880135,9.75877212797992,FGA
"DNA-templated transcription, termination (GO:0006353)",1/70,0.1726957796087883,0.20917128977387783,0,0,5.435329505058792,9.545654667103056,CDK7
positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1726957796087883,0.20917128977387783,0,0,5.435329505058792,9.545654667103056,FGA
snRNA transcription by RNA polymerase II (GO:0042795),1/70,0.1726957796087883,0.20917128977387783,0,0,5.435329505058792,9.545654667103056,CDK7
phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.17493734325009064,0.21078701929874727,0,0,5.3574123989218325,9.339723869609994,ERBB2
positive regulation of cellular protein localization (GO:1903829),1/71,0.17493734325009064,0.21078701929874727,0,0,5.3574123989218325,9.339723869609994,CDK1
gland development (GO:0048732),1/71,0.17493734325009064,0.21078701929874727,0,0,5.3574123989218325,9.339723869609994,ANXA1
snRNA transcription (GO:0009301),1/71,0.17493734325009064,0.21078701929874727,0,0,5.3574123989218325,9.339723869609994,CDK7
cell junction organization (GO:0034330),1/72,0.1771729455832538,0.2126533158227943,0,0,5.28169014084507,9.140645755790116,VASP
cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1771729455832538,0.2126533158227943,0,0,5.28169014084507,9.140645755790116,RB1
cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.1771729455832538,0.2126533158227943,0,0,5.28169014084507,9.140645755790116,CENPA
regulation of actin filament polymerization (GO:0030833),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,VASP
regulation of actin filament-based process (GO:0032970),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,MTOR
regulation of hydrolase activity (GO:0051336),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,PPP1R17
regulation of Rho protein signal transduction (GO:0035023),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,RAF1
granulocyte chemotaxis (GO:0071621),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,ANXA1
positive regulation of JNK cascade (GO:0046330),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,CD27
transcription-coupled nucleotide-excision repair (GO:0006283),1/73,0.1794026022045267,0.21339951017670333,0,0,5.208071278825996,8.948106135360762,CDK7
cellular response to amino acid starvation (GO:0034198),1/74,0.18162632858411695,0.2157683622182157,0,0,5.136469371930732,8.761809189641154,MTOR
response to amino acid starvation (GO:1990928),1/75,0.18384414020581769,0.21756841560663007,0,0,5.066802651708312,8.581476165166299,MTOR
positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.18384414020581769,0.21756841560663007,0,0,5.066802651708312,8.581476165166299,ANXA1
positive regulation of T cell activation (GO:0050870),1/75,0.18384414020581769,0.21756841560663007,0,0,5.066802651708312,8.581476165166299,ANXA1
cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,RB1
regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,MTOR
cellular response to hormone stimulus (GO:0032870),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,AR
regulation of T cell proliferation (GO:0042129),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,ANXA1
positive regulation of interleukin-6 production (GO:0032755),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,MBP
RNA transport (GO:0050658),1/76,0.1860560525481816,0.2185158948385091,0,0,4.998993710691824,8.406844180342443,EIF4E
purine ribonucleotide metabolic process (GO:0009150),1/77,0.1882620809769539,0.22027137686094483,0,0,4.932969215491559,8.237665132225366,BAD
positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1882620809769539,0.22027137686094483,0,0,4.932969215491559,8.237665132225366,NR4A1
inorganic cation import across plasma membrane (GO:0098659),1/77,0.1882620809769539,0.22027137686094483,0,0,4.932969215491559,8.237665132225366,CACNA2D1
negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.190462240808856,0.2225653103288392,0,0,4.868659642244548,8.073704687210991,RB1
DNA repair (GO:0006281),2/298,0.1922203045558422,0.22433751624670523,0,0,2.5532744282744284,4.210638422907518,CDK1;TP53
regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.19484501606792143,0.22626377490887375,0,0,4.744924767136374,7.760565621373132,CD27
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.19484501606792143,0.22626377490887375,0,0,4.744924767136374,7.760565621373132,AR
positive regulation of cell adhesion (GO:0045785),1/80,0.19484501606792143,0.22626377490887375,0,0,4.744924767136374,7.760565621373132,ERBB2
skin development (GO:0043588),1/80,0.19484501606792143,0.22626377490887375,0,0,4.744924767136374,7.760565621373132,ANXA1
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.19702766198051563,0.22822780296745515,0,0,4.685377358490566,7.610979194775059,BAD
regulation of interleukin-8 production (GO:0032677),1/81,0.19702766198051563,0.22822780296745515,0,0,4.685377358490566,7.610979194775059,ANXA1
"regulation of gene expression, epigenetic (GO:0040029)",1/82,0.19920450038996365,0.23017534933118936,0,0,4.627300256231074,7.465794242771092,H3C13
positive regulation of cytoskeleton organization (GO:0051495),1/82,0.19920450038996365,0.23017534933118936,0,0,4.627300256231074,7.465794242771092,VASP
regulation of defense response (GO:0031347),1/83,0.2013755464220889,0.23239488524983923,0,0,4.570639668660838,7.3248327414165475,ANXA1
nuclear export (GO:0051168),1/84,0.20354081521299808,0.23431154564172887,0,0,4.51534439645374,7.187925847991766,EIF4E
spindle assembly (GO:0051225),1/84,0.20354081521299808,0.23431154564172887,0,0,4.51534439645374,7.187925847991766,NEK2
negative regulation of defense response (GO:0031348),1/85,0.2057003218403385,0.23650445419514168,0,0,4.4613656783468105,7.054913327861288,RB1
regulation of Ras protein signal transduction (GO:0046578),1/86,0.20785408138648875,0.2383906686519112,0,0,4.40865704772475,6.92564302052444,RAF1
response to interleukin-1 (GO:0070555),1/86,0.20785408138648875,0.2383906686519112,0,0,4.40865704772475,6.92564302052444,ANXA1
calcium ion transmembrane transport (GO:0070588),1/87,0.210002108814943,0.2402610333609385,0,0,4.35717419921018,6.799970348375583,CACNA2D1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.210002108814943,0.2402610333609385,0,0,4.35717419921018,6.799970348375583,TP53
metal ion transport (GO:0030001),1/88,0.21214441912542104,0.24241348753692027,0,0,4.306874864454565,6.677757854906344,CACNA2D1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.2148794596751133,0.2452371228970273,0,0,2.3664094526163493,3.6387758980463087,RB1;CDK1
cellular amino acid catabolic process (GO:0009063),1/90,0.21641194796983468,0.2460791917551731,0,0,4.209667161331355,6.443196670460662,BCKDK
negative regulation of protein kinase activity (GO:0006469),1/90,0.21641194796983468,0.2460791917551731,0,0,4.209667161331355,6.443196670460662,RB1
positive regulation of binding (GO:0051099),1/90,0.21641194796983468,0.2460791917551731,0,0,4.209667161331355,6.443196670460662,ADD2
regulation of actin cytoskeleton organization (GO:0032956),1/91,0.21853719627074508,0.24788895645362904,0,0,4.1626834381551365,6.330604994411687,MTOR
toll-like receptor signaling pathway (GO:0002224),1/91,0.21853719627074508,0.24788895645362904,0,0,4.1626834381551365,6.330604994411687,FGA
regulation of endothelial cell proliferation (GO:0001936),1/92,0.22065678694231972,0.24937975069271903,0,0,4.116732324279494,6.2209868160475805,NR4A1
cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.22065678694231972,0.24937975069271903,0,0,4.116732324279494,6.2209868160475805,NR4A1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.22065678694231972,0.24937975069271903,0,0,4.116732324279494,6.2209868160475805,TP53
positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2227707347342889,0.25146295573287286,0,0,4.071780147662018,6.114234467493096,RAF1
positive regulation of epithelial cell migration (GO:0010634),1/94,0.2248790544166993,0.25322744430680444,0,0,4.027794684520186,6.010245250282423,MTOR
hemopoiesis (GO:0030097),1/94,0.2248790544166993,0.25322744430680444,0,0,4.027794684520186,6.010245250282423,TP53
mRNA metabolic process (GO:0016071),1/95,0.2269817606631972,0.25528578166599303,0,0,3.9847450822962656,5.908921158911916,TP53
positive regulation of cytokine production (GO:0001819),2/335,0.2288016002400983,0.2570213864849472,0,0,2.265303765303765,3.3410965810862234,ANXA1;MBP
regulation of vesicle-mediated transport (GO:0060627),1/96,0.2290788681344704,0.2570220634020809,0,0,3.942601787487587,5.810168619029014,MAP2K1
regulation of MAP kinase activity (GO:0043405),1/97,0.23117039149347784,0.259055842819591,0,0,3.901336477987421,5.713898243899374,ERBB2
regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.23325634531533676,0.2610784877083709,0,0,3.8609219996109703,5.6200246083287,RAF1
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.235336744091168,0.2627738404575662,0,0,3.8213323065075087,5.528466035409756,CD27
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.235336744091168,0.2627738404575662,0,0,3.8213323065075087,5.528466035409756,EIF4E
cell-matrix adhesion (GO:0007160),1/100,0.23741160244685375,0.26477236335309384,0,0,3.7825424051839143,5.43914439332398,FGA
positive regulation of cellular process (GO:0048522),3/625,0.23801260399318425,0.2651243514504414,0,0,1.8275014185738605,2.623253374371663,AR;RPS6KA1;ERBB2
cellular response to chemical stress (GO:0062197),1/101,0.2394809348002207,0.2664404651849162,0,0,3.744528301886792,5.351984913808453,FOXO3
cell junction assembly (GO:0034329),1/102,0.2415447555791644,0.2684151649916791,0,0,3.707266953110405,5.266916012992776,VASP
cellular response to DNA damage stimulus (GO:0006974),2/350,0.24379181525045288,0.2705885261262494,0,0,2.166003536693192,3.0571854052318006,CDK1;TP53
mRNA transport (GO:0051028),1/104,0.2456559199877992,0.2723321595091473,0,0,3.634914819564023,5.102778558422387,EIF4E
regulation of JNK cascade (GO:0046328),1/105,0.24770329237259123,0.2742745633064806,0,0,3.5997822931785195,5.023581327863361,CD27
protein processing (GO:0016485),1/106,0.24974521057517932,0.2755502382711896,0,0,3.565318957771788,4.946217041895164,C1R
chromosome organization (GO:0051276),1/106,0.24974521057517932,0.2755502382711896,0,0,3.565318957771788,4.946217041895164,H3C13
RNA export from nucleus (GO:0006405),1/106,0.24974521057517932,0.2755502382711896,0,0,3.565318957771788,4.946217041895164,EIF4E
response to calcium ion (GO:0051592),1/107,0.25178168885115515,0.2771388494582028,0,0,3.531505873976504,4.870627760669909,FGA
mRNA export from nucleus (GO:0006406),1/107,0.25178168885115515,0.2771388494582028,0,0,3.531505873976504,4.870627760669909,EIF4E
DNA replication (GO:0006260),1/108,0.25381274145450977,0.2790438305458457,0,0,3.498324810439076,4.796757877346515,CDK1
regulation of interleukin-6 production (GO:0032675),1/110,0.25785862628579265,0.2824889903531856,0,0,3.4337891639259133,4.653964868867731,MBP
regulation of protein kinase activity (GO:0045859),1/110,0.25785862628579265,0.2824889903531856,0,0,3.4337891639259133,4.653964868867731,RB1
response to endoplasmic reticulum stress (GO:0034976),1/110,0.25785862628579265,0.2824889903531856,0,0,3.4337891639259133,4.653964868867731,TP53
regulation of Wnt signaling pathway (GO:0030111),1/111,0.25987348673890226,0.2843609766554066,0,0,3.402401372212693,4.584941203901978,ESR1
regulation of cytoskeleton organization (GO:0051493),1/112,0.2618829780379357,0.28588635322825184,0,0,3.3715791262961075,4.517435659146221,MTOR
regulation of macroautophagy (GO:0016241),1/112,0.2618829780379357,0.28588635322825184,0,0,3.3715791262961075,4.517435659146221,MTOR
negative regulation of cell motility (GO:2000146),1/114,0.26588590923208694,0.28957562681900206,0,0,3.3115712138921354,4.38679856497224,FOXO3
positive regulation of kinase activity (GO:0033674),1/114,0.26588590923208694,0.28957562681900206,0,0,3.3115712138921354,4.38679856497224,ERBB2
calcium ion transport (GO:0006816),1/115,0.2678793770573336,0.29140508347337574,0,0,3.2823568354849386,4.323581099370532,CACNA2D1
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2738279567355554,0.29683333933177475,0,0,3.1977100467666504,4.14185077378919,GPR6
negative regulation of response to external stimulus (GO:0032102),1/118,0.2738279567355554,0.29683333933177475,0,0,3.1977100467666504,4.14185077378919,RB1
regulation of protein binding (GO:0043393),1/118,0.2738279567355554,0.29683333933177475,0,0,3.1977100467666504,4.14185077378919,ADD2
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.27580025484775794,0.29862288665916914,0,0,3.170450911416693,4.08378930425916,BAD
cytoskeleton organization (GO:0007010),1/120,0.2777672950864116,0.3004025810655138,0,0,3.143649912795307,4.026926207904397,CFL1
cellular response to interferon-gamma (GO:0071346),1/121,0.27972909123089545,0.3021724718063976,0,0,3.1172955974842766,3.971227838097148,CAMK2G
epithelium development (GO:0060429),1/122,0.2816856569494322,0.30393260778864406,0,0,3.091376890690784,3.916661751538747,CDK1
cellular response to organic substance (GO:0071310),1/123,0.2836370059612168,0.30568303774706546,0,0,3.065883080729972,3.86319665424253,ERBB2
regulation of phosphorylation (GO:0042325),1/125,0.28752410838833287,0.3091549730240292,0,0,3.0161290322580645,3.759449710134971,AR
platelet degranulation (GO:0002576),1/125,0.28752410838833287,0.3091549730240292,0,0,3.0161290322580645,3.759449710134971,FGA
plasma membrane bounded cell projection organization (GO:0120036),1/128,0.29331597663197484,0.31465420587887366,0,0,2.944436190759174,3.611365216958303,RB1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/128,0.29331597663197484,0.31465420587887366,0,0,2.944436190759174,3.611365216958303,CENPA
regulation of response to external stimulus (GO:0032101),1/130,0.2971515228201141,0.3180342911289009,0,0,2.898493491297353,3.517359800013655,ANXA1
Golgi organization (GO:0007030),1/130,0.2971515228201141,0.3180342911289009,0,0,2.898493491297353,3.517359800013655,CDK1
regulation of cell migration (GO:0030334),2/408,0.301969765723241,0.3228192317110367,0,0,1.8510799545282304,2.2165356714199365,ANXA1;FOXO3
regulation of cell adhesion (GO:0030155),1/133,0.3028665615425825,0.323405788129953,0,0,2.8321898227558604,3.382945842997971,ERBB2
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.30476141969101106,0.3250555211170485,0,0,2.81075329834019,3.339810258287141,TP53
protein localization to plasma membrane (GO:0072659),1/136,0.3085359835030053,0.32832752425463,0,0,2.768832983927324,3.2559172283809583,KCNB1
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.3085359835030053,0.32832752425463,0,0,2.768832983927324,3.2559172283809583,PRKACG
regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.3104157155874621,0.32994988533266856,0,0,2.748335183129856,3.215120295929532,PRKACG
protein dephosphorylation (GO:0006470),1/139,0.31416014594522135,0.3335483149521264,0,0,2.7082307902652447,3.135731531516588,PPP2CB
enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.3160248704252871,0.3347629471209712,0,0,2.688611375050902,3.097103836015175,ERBB2
protein localization to cell periphery (GO:1990778),1/140,0.3160248704252871,0.3347629471209712,0,0,2.688611375050902,3.097103836015175,KCNB1
organelle assembly (GO:0070925),2/425,0.3189502312544445,0.3374769531154658,0,0,1.7751409347154028,2.02848940970691,NEK2;CENPA
negative regulation of cell migration (GO:0030336),1/144,0.32343413500046725,0.341831981132462,0,0,2.6128776883493865,2.9493112629733527,FOXO3
regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3307646079806067,0.3491821827431632,0,0,2.5412655628289054,2.811524862557845,ESR1
positive regulation of hydrolase activity (GO:0051345),1/149,0.33258501155690634,0.3507054208131283,0,0,2.523967363590005,2.7785341508286368,ERBB2
regulation of cytokine production (GO:0001817),1/150,0.33440055490417686,0.35182119536351114,0,0,2.506901354944916,2.7460991987490533,ANXA1
response to cytokine (GO:0034097),1/150,0.33440055490417686,0.35182119536351114,0,0,2.506901354944916,2.7460991987490533,ANXA1
actin filament organization (GO:0007015),1/152,0.3380171115569395,0.3548224820750246,0,0,2.4734474572035485,2.6828464490666466,MARCKS
negative regulation of protein phosphorylation (GO:0001933),1/152,0.3380171115569395,0.3548224820750246,0,0,2.4734474572035485,2.6828464490666466,RB1
dephosphorylation (GO:0016311),1/153,0.3398181503324097,0.3563104533395132,0,0,2.4570506454816288,2.6520044847533275,PPP2CB
positive regulation of protein kinase activity (GO:0045860),1/154,0.3416143795485933,0.3577900322442425,0,0,2.440868171167838,2.621669923716089,MAP2K1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.34340581176294793,0.35926126027903,0,0,2.424895858858123,2.5918315252533666,AR
mitotic spindle organization (GO:0007052),1/157,0.3469743356882705,0.36258622930754025,0,0,2.3935655539429126,2.533599819711265,CENPA
negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.35753283373237665,0.3732000028509864,0,0,1.622044622044622,1.6683184382835563,RB1;TP53
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3610590516999416,0.37645775424157774,0,0,2.275885872066268,2.3184762447563068,GPR6
neuron projection development (GO:0031175),1/171,0.37142650185754833,0.38683320653101166,0,0,2.194894561598224,2.173832959100051,RB1
neutrophil degranulation (GO:0043312),2/481,0.3741305926982148,0.38921312499064,0,0,1.5631122530913764,1.5367743808789758,RAP1B;PFKL
neutrophil activation involved in immune response (GO:0002283),2/485,0.37801276395185823,0.3928119213772665,0,0,1.549848702022615,1.5077351543341793,RAP1B;PFKL
neutrophil mediated immunity (GO:0002446),2/488,0.38091825661389633,0.3953888942953181,0,0,1.5400443178220955,1.4864053079777098,RAP1B;PFKL
negative regulation of immune response (GO:0050777),1/178,0.3833133021831732,0.3974308680001874,0,0,2.1073446327683616,2.020738253426957,PRKACG
protein stabilization (GO:0050821),1/179,0.3849933053088833,0.3987277376052983,0,0,2.0953996184015264,2.0001204014908907,CDK7
regulated exocytosis (GO:0045055),1/180,0.3866688162461148,0.40001707159536826,0,0,2.0835880678823653,1.9797977210285784,FGA
negative regulation of cytokine production (GO:0001818),1/182,0.3900064085237779,0.4030210828905335,0,0,2.0603565099551755,1.9400154291954452,ANXA1
regulation of GTPase activity (GO:0043087),1/189,0.4015481994798117,0.41448697479638336,0,0,1.9829385788839824,1.809288095265265,ERBB2
negative regulation of cell differentiation (GO:0045596),1/191,0.4048062992601041,0.4173862952415501,0,0,1.9618669314796424,1.7742076885801688,RB1
protein localization to membrane (GO:0072657),1/195,0.4112703567735608,0.42358111024682704,0,0,1.9210270375413343,1.7068411259335678,KCNB1
negative regulation of intracellular signal transduction (GO:1902532),1/198,0.4160731339213949,0.4275795812090441,0,0,1.891485489895604,1.6586327150113274,ESR1
regulation of signal transduction (GO:0009966),1/198,0.4160731339213949,0.4275795812090441,0,0,1.891485489895604,1.6586327150113274,ESR1
regulation of angiogenesis (GO:0045765),1/203,0.42399244360829513,0.4347560486888589,0,0,1.8441995142910519,1.582396297635001,ERBB2
axon guidance (GO:0007411),1/203,0.42399244360829513,0.4347560486888589,0,0,1.8441995142910519,1.582396297635001,VASP
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.4368478719431364,0.4474439614500261,0,0,1.3691601976005645,1.133897761781219,RB1;TP53
negative regulation of multicellular organismal process (GO:0051241),1/214,0.4410457119359288,0.4502543586686569,0,0,1.747984763929489,1.4309121331586434,RB1
positive regulation of GTPase activity (GO:0043547),1/214,0.4410457119359288,0.4502543586686569,0,0,1.747984763929489,1.4309121331586434,ERBB2
positive regulation of protein modification process (GO:0031401),1/214,0.4410457119359288,0.4502543586686569,0,0,1.747984763929489,1.4309121331586434,ERBB2
extracellular structure organization (GO:0043062),1/216,0.4440926180523509,0.4528672252147464,0,0,1.7315489249670908,1.4055365973075582,FGA
external encapsulating structure organization (GO:0045229),1/217,0.4456099521259254,0.4539162779879219,0,0,1.723445143256464,1.3930801090891642,FGA
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4561180659629848,0.46411137270494296,0,0,1.6687537016668077,1.3099776406189976,ESR1
inflammatory response (GO:0006954),1/230,0.4649692383652322,0.47260002455284544,0,0,1.6245365411551451,1.2440441387772376,ANXA1
axonogenesis (GO:0007409),1/240,0.47940802183094144,0.4867432265365516,0,0,1.555774848030315,1.143810684179804,VASP
regulation of protein phosphorylation (GO:0001932),1/266,0.5151828813644878,0.5224944288074335,0,0,1.4012815948736206,0.9293766611111112,ERBB2
positive regulation of cell migration (GO:0030335),1/269,0.519152143527187,0.5259458466049691,0,0,1.3853843987609125,0.9082002292791016,MTOR
DNA metabolic process (GO:0006259),1/277,0.52958156940524,0.535927318058244,0,0,1.3446814328684715,0.8547710591795552,CDK1
plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5308695342257318,0.5366461341628997,0,0,1.3397588720114433,0.8483875498456699,RAP1B
extracellular matrix organization (GO:0030198),1/300,0.5583450282543575,0.5631949307799111,0,0,1.2397930207610273,0.7225243170955516,FGA
mRNA processing (GO:0006397),1/300,0.5583450282543575,0.5631949307799111,0,0,1.2397930207610273,0.7225243170955516,CDK7
cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5750004758179555,0.5793659891918447,0,0,1.1834950871059136,0.6549277313156224,CDK1
post-translational protein modification (GO:0043687),1/345,0.6097172879205403,0.613680780583079,0,0,1.0751426064063183,0.531937439477573,FGA
gene expression (GO:0010467),1/356,0.6213543305593403,0.6247166375428864,0,0,1.0412436885463725,0.49547974421819446,EIF4E
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6682729713840554,0.6711628004494999,0,0,0.9149772929444262,0.3687894201714719,ERBB2
protein modification by small protein conjugation (GO:0032446),1/409,0.672818935401228,0.6749986943712103,0,0,0.9035331113577506,0.35805122181913057,H2BC3
cellular protein metabolic process (GO:0044267),1/417,0.6799656017287966,0.6814326256807466,0,0,0.8857946298984035,0.3416625641250871,FGA
organelle organization (GO:0006996),1/420,0.6826059098432884,0.6833414765564816,0,0,0.8793173323726753,0.3357564063819972,CFL1
protein ubiquitination (GO:0016567),1/525,0.7626844971175952,0.7626844971175952,0,0,0.699337462192136,0.18945809676362949,H2BC3
